Summary of selected studies that provide risk estimates of the associations between dietary and supplemental vitamins and micronutrients (antioxidants) and breast cancer risk.
\r\n\t
",isbn:null,printIsbn:"979-953-307-X-X",pdfIsbn:null,doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!1,hash:"abf31c9873fc2d88b8ee05c6adb53a29",bookSignature:"Dr. David Bienvenido-Huertas",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/10104.jpg",keywords:"Sustainable Construction, Innovative Construction, Construction Processes, Sustainable Design, Design Optimization, Maintenance Minimization, Energy Efficiency, Energy Conservation Measures, Thermal Comfort, Socio-cultural Integration, Urban Environment, Visual Impact",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:0,numberOfDimensionsCitations:0,numberOfTotalCitations:0,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"August 26th 2020",dateEndSecondStepPublish:"September 23rd 2020",dateEndThirdStepPublish:"November 22nd 2020",dateEndFourthStepPublish:"February 10th 2021",dateEndFifthStepPublish:"April 11th 2021",remainingDaysToSecondStep:"5 months",secondStepPassed:!0,currentStepOfPublishingProcess:5,editedByType:null,kuFlag:!1,biosketch:"David Bienvenido-Huertas has completed his Ph.D. as an Architect, currently, he is a researcher of the Building Construction II Department at Universidad de Sevilla, Spain",coeditorOneBiosketch:null,coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"320815",title:"Dr.",name:"David",middleName:null,surname:"Bienvenido-Huertas",slug:"david-bienvenido-huertas",fullName:"David Bienvenido-Huertas",profilePictureURL:"https://mts.intechopen.com/storage/users/320815/images/system/320815.jpg",biography:"PhD Architect. Researcher of the Building Construction II Department at Universidad de Sevilla, Spain. Active member of the Research Group TEP970: Technological Innovation, 3d Modeling Systems and Energy Diagnosis in Heritage and Building at the Universidad de Sevilla. His area of expertise covers climate change in the building sector, adaptive thermal comfort, heat transfer, fuel poverty, energy conservation measures, and design of nearly zero energy buildings. He is an author of more than 25 manuscripts and frequently a reviewer of international peer-reviewed journals.",institutionString:"University of Seville",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"University of Seville",institutionURL:null,country:{name:"Spain"}}}],coeditorOne:null,coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"11",title:"Engineering",slug:"engineering"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"194667",firstName:"Marijana",lastName:"Francetic",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/194667/images/4752_n.jpg",email:"marijana@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"878",title:"Phytochemicals",subtitle:"A Global Perspective of Their Role in Nutrition and Health",isOpenForSubmission:!1,hash:"ec77671f63975ef2d16192897deb6835",slug:"phytochemicals-a-global-perspective-of-their-role-in-nutrition-and-health",bookSignature:"Venketeshwer Rao",coverURL:"https://cdn.intechopen.com/books/images_new/878.jpg",editedByType:"Edited by",editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4816",title:"Face Recognition",subtitle:null,isOpenForSubmission:!1,hash:"146063b5359146b7718ea86bad47c8eb",slug:"face_recognition",bookSignature:"Kresimir Delac and Mislav Grgic",coverURL:"https://cdn.intechopen.com/books/images_new/4816.jpg",editedByType:"Edited by",editors:[{id:"528",title:"Dr.",name:"Kresimir",surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3621",title:"Silver Nanoparticles",subtitle:null,isOpenForSubmission:!1,hash:null,slug:"silver-nanoparticles",bookSignature:"David Pozo Perez",coverURL:"https://cdn.intechopen.com/books/images_new/3621.jpg",editedByType:"Edited by",editors:[{id:"6667",title:"Dr.",name:"David",surname:"Pozo",slug:"david-pozo",fullName:"David Pozo"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"35996",title:"Complex Regulatory Interplay Between Multidrug Resistance and Oxidative Stress Response in Yeast: The FLR1 Regulatory Network as a Systems Biology Case-Study",doi:"10.5772/32603",slug:"complex-regulatory-interplay-between-multidrug-resistance-and-oxidative-stress-response-in-yeast-th",body:null,keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/35996.pdf",chapterXML:null,downloadPdfUrl:"/chapter/pdf-download/35996",previewPdfUrl:"/chapter/pdf-preview/35996",totalDownloads:1822,totalViews:111,totalCrossrefCites:0,totalDimensionsCites:0,hasAltmetrics:0,dateSubmitted:"April 12th 2011",dateReviewed:"November 4th 2011",datePrePublished:null,datePublished:"April 25th 2012",dateFinished:null,readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/35996",risUrl:"/chapter/ris/35996",book:{slug:"oxidative-stress-molecular-mechanisms-and-biological-effects"},signatures:"Miguel C. Teixeira",authors:[{id:"16150",title:"Dr.",name:"Miguel",middleName:null,surname:"Teixeira",fullName:"Miguel Teixeira",slug:"miguel-teixeira",email:"mnpct@ist.utl.pt",position:null,institution:null}],sections:null,chapterReferences:null,footnotes:null,contributors:null,corrections:null},book:{id:"1910",title:"Oxidative Stress",subtitle:"Molecular Mechanisms and Biological Effects",fullTitle:"Oxidative Stress - Molecular Mechanisms and Biological Effects",slug:"oxidative-stress-molecular-mechanisms-and-biological-effects",publishedDate:"April 25th 2012",bookSignature:"Volodymyr Lushchak and Halyna M. Semchyshyn",coverURL:"https://cdn.intechopen.com/books/images_new/1910.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"96151",title:"Dr.",name:"Volodymyr",middleName:"I",surname:"Lushchak",slug:"volodymyr-lushchak",fullName:"Volodymyr Lushchak"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"35980",title:"Introductory Chapter",slug:"introduction-chapter1",totalDownloads:1529,totalCrossrefCites:0,signatures:"Volodymyr I. Lushchak and Halyna M. Semchyshyn",authors:[{id:"96151",title:"Dr.",name:"Volodymyr",middleName:"I",surname:"Lushchak",fullName:"Volodymyr Lushchak",slug:"volodymyr-lushchak"}]},{id:"35981",title:"Interplay Between Oxidative and Carbonyl Stresses: Molecular Mechanisms, Biological Effects and Therapeutic Strategies of Protection",slug:"interplay-between-oxidative-and-carbonyl-stresses-molecular-mechanisms-biological-effects-and-ther",totalDownloads:4024,totalCrossrefCites:1,signatures:"Halyna M. Semchyshyn and Volodymyr I. Lushchak",authors:[{id:"96151",title:"Dr.",name:"Volodymyr",middleName:"I",surname:"Lushchak",fullName:"Volodymyr Lushchak",slug:"volodymyr-lushchak"},{id:"108658",title:"Dr.",name:"Halyna",middleName:null,surname:"Semchyshyn",fullName:"Halyna Semchyshyn",slug:"halyna-semchyshyn"}]},{id:"35982",title:"Oxidative and Nitrosative Stresses: Their Role in Health and Disease in Man and Birds",slug:"oxidative-and-nitrosative-stresses-their-role-in-health-and-disease-in-man-and-birds",totalDownloads:3688,totalCrossrefCites:7,signatures:"Hillar Klandorf and Knox Van Dyke",authors:[{id:"97552",title:"Prof.",name:"Hillar",middleName:null,surname:"Klandorf",fullName:"Hillar Klandorf",slug:"hillar-klandorf"},{id:"128379",title:"Prof.",name:"Knox",middleName:null,surname:"Van Dyke",fullName:"Knox Van Dyke",slug:"knox-van-dyke"}]},{id:"35983",title:"Nitric Oxide Synthase and Oxidative Stress: Regulation of Nitric Oxide Synthase",slug:"nitric-oxide-synthase-as-oxidative-stress-regulation-of-nitric-oxide-synthase",totalDownloads:3129,totalCrossrefCites:2,signatures:"Ehab M. M. Ali, Soha M. Hamdy and Tarek M. Mohamed",authors:[{id:"29143",title:"Prof.",name:"Tarek",middleName:"Mostafa",surname:"Mohamed",fullName:"Tarek Mohamed",slug:"tarek-mohamed"},{id:"33117",title:"Prof.",name:"Ehab",middleName:null,surname:"Ali",fullName:"Ehab Ali",slug:"ehab-ali"},{id:"33118",title:"Prof.",name:"Soha",middleName:"Mohamed",surname:"Hamdy",fullName:"Soha Hamdy",slug:"soha-hamdy"}]},{id:"35984",title:"Iron, Oxidative Stress and Health",slug:"iron-oxidative-stress-and-health-authors",totalDownloads:3574,totalCrossrefCites:3,signatures:"Shobha Udipi, Padmini Ghugre and Chanda Gokhale",authors:[{id:"76965",title:"Dr.",name:"Chanda",middleName:null,surname:"Gokhale",fullName:"Chanda Gokhale",slug:"chanda-gokhale"},{id:"102454",title:"Dr.",name:"Shobha",middleName:null,surname:"Udipi",fullName:"Shobha Udipi",slug:"shobha-udipi"},{id:"108752",title:"Dr.",name:"Padmini",middleName:null,surname:"Ghugre",fullName:"Padmini Ghugre",slug:"padmini-ghugre"}]},{id:"35985",title:"Heme Proteins, Heme Oxygenase-1 and Oxidative Stress",slug:"heme-proteins-hemeoxygenase-1-and-oxidative-stress",totalDownloads:3129,totalCrossrefCites:2,signatures:"Hiroshi Morimatsu, Toru Takahashi, Hiroko Shimizu, Junya Matsumi, Junko Kosaka and Kiyoshi Morita",authors:[{id:"96949",title:"Dr.",name:"Hiroshi",middleName:null,surname:"Morimatsu",fullName:"Hiroshi Morimatsu",slug:"hiroshi-morimatsu"},{id:"102714",title:"Prof.",name:"Toru",middleName:null,surname:"Takahashi",fullName:"Toru Takahashi",slug:"toru-takahashi"},{id:"102716",title:"Dr.",name:"Hiroko",middleName:null,surname:"Shimizu",fullName:"Hiroko Shimizu",slug:"hiroko-shimizu"},{id:"102717",title:"Dr.",name:"Junya",middleName:null,surname:"Matsumi",fullName:"Junya Matsumi",slug:"junya-matsumi"},{id:"102718",title:"Dr.",name:"Junko",middleName:null,surname:"Kosaka",fullName:"Junko Kosaka",slug:"junko-kosaka"},{id:"135353",title:"Prof.",name:"Kiyoshi",middleName:null,surname:"Morita",fullName:"Kiyoshi Morita",slug:"kiyoshi-morita"}]},{id:"35986",title:"Assessment of the General Oxidant Status of Individuals in Non-Invasive Samples",slug:"assessment-of-the-general-oxidant-status-of-individuals-in-non-invasive-samples",totalDownloads:1591,totalCrossrefCites:0,signatures:"Sandro Argüelles, Mercedes Cano, Mario F. Muñoz-Pinto, Rafael Ayala, Afrah Ismaiel and Antonio Ayala",authors:[{id:"92020",title:"Dr",name:null,middleName:null,surname:"Ayala",fullName:"Ayala",slug:"ayala"}]},{id:"35987",title:"Hydrogen: From a Biologically Inert Gas to a Unique Antioxidant",slug:"hydrogen-from-a-biologically-inert-gas-to-a-unique-antioxidant",totalDownloads:3433,totalCrossrefCites:1,signatures:"Shulin Liu, Xuejun Sun and Hengyi Tao",authors:[{id:"102149",title:"Prof.",name:"Hengyi",middleName:null,surname:"Tao",fullName:"Hengyi Tao",slug:"hengyi-tao"},{id:"102151",title:"Dr.",name:"Shulin",middleName:null,surname:"Liu",fullName:"Shulin Liu",slug:"shulin-liu"},{id:"102720",title:"Prof.",name:"Xuejun",middleName:null,surname:"Sun",fullName:"Xuejun Sun",slug:"xuejun-sun"}]},{id:"35988",title:"Paraoxonase: A New Biochemical Marker of Oxidant-Antioxidant Status in Atherosclerosis",slug:"paraoxonase-a-new-biochemical-marker-of-oxidant-antioxidant-status-in-atherosclerosis",totalDownloads:2252,totalCrossrefCites:0,signatures:"Tünay Kontaş Aşkar and Olga Büyükleblebici",authors:[{id:"102425",title:"Dr.",name:"Tünay",middleName:null,surname:"Kontaş Aşkar",fullName:"Tünay Kontaş Aşkar",slug:"tunay-kontas-askar"},{id:"130281",title:"Dr.",name:"Olga",middleName:null,surname:"Büyükleblebici",fullName:"Olga Büyükleblebici",slug:"olga-buyukleblebici"}]},{id:"35989",title:"Renal Redox Balance and Na+, K+-ATPase Regulation: Role in Physiology and Pathophysiology",slug:"renal-redox-balance-and-na-k-atpase-regulation-role-in-physiology-and-pathophysiology",totalDownloads:2040,totalCrossrefCites:2,signatures:"Elisabete Silva and Patrício Soares-da-Silva",authors:[{id:"101393",title:"Prof.",name:"Patricio",middleName:null,surname:"Soares-Da-Silva",fullName:"Patricio Soares-Da-Silva",slug:"patricio-soares-da-silva"},{id:"101397",title:"PhD.",name:"Elisabete",middleName:null,surname:"Silva",fullName:"Elisabete Silva",slug:"elisabete-silva"}]},{id:"35990",title:"Effects of Oxidative Stress and Antenatal Corticosteroids on the Pulmonary Expression of Vascular Endothelial Growth Factor (VEGF) and Alveolarization",slug:"effects-of-oxidative-stress-and-antenatal-corticosteroids-on-the-lung-expression-of-vascular-endothe",totalDownloads:1800,totalCrossrefCites:0,signatures:"Ana Remesal, Laura San Feliciano and Dolores Ludena",authors:[{id:"97843",title:"Dr.",name:"Ana",middleName:null,surname:"Remesal",fullName:"Ana Remesal",slug:"ana-remesal"},{id:"101327",title:"Dr.",name:"Laura",middleName:null,surname:"San Feliciano",fullName:"Laura San Feliciano",slug:"laura-san-feliciano"},{id:"101329",title:"Prof.",name:"Dolores",middleName:null,surname:"Ludeña",fullName:"Dolores Ludeña",slug:"dolores-ludena"}]},{id:"35991",title:"Protection of Mouse Embryonic Stem Cells from Oxidative Stress by Methionine Sulfoxide Reductases",slug:"protection-of-mouse-embryonic-stem-cells-from-oxidative-stress-by-methionine-sulfoxide-reductases",totalDownloads:1779,totalCrossrefCites:0,signatures:"Larry F. Lemanski, Chi Zhang, Andrei Kochegarov, Ashley Moses, William Lian, Jessica Meyer, Pingping Jia, Yuanyuan Jia, Yuejin Li, Keith A. Webster, Xupei Huang, Michael Hanna, Mohan P. Achary, Sharon L. Lemanski and Herbert Weissbach",authors:[{id:"98675",title:"Prof.",name:"Herbert",middleName:null,surname:"Weissbach",fullName:"Herbert Weissbach",slug:"herbert-weissbach"},{id:"98845",title:"Dr",name:"Larry",middleName:"F.",surname:"Lemanski",fullName:"Larry Lemanski",slug:"larry-lemanski"},{id:"102060",title:"Dr.",name:"Chi",middleName:null,surname:"Zhang",fullName:"Chi Zhang",slug:"chi-zhang"},{id:"102063",title:"Mr.",name:"Pingping",middleName:null,surname:"Jia",fullName:"Pingping Jia",slug:"pingping-jia"},{id:"102065",title:"Mrs.",name:"Yuanyuan",middleName:null,surname:"Jia",fullName:"Yuanyuan Jia",slug:"yuanyuan-jia"},{id:"102067",title:"Dr.",name:"Yuejin",middleName:null,surname:"Li",fullName:"Yuejin Li",slug:"yuejin-li"},{id:"102069",title:"Dr.",name:"Keith A.",middleName:null,surname:"Webster",fullName:"Keith A. Webster",slug:"keith-a.-webster"},{id:"102070",title:"Dr.",name:"Xupei",middleName:null,surname:"Huang",fullName:"Xupei Huang",slug:"xupei-huang"},{id:"102071",title:"Dr.",name:"Mohan",middleName:null,surname:"Achary",fullName:"Mohan Achary",slug:"mohan-achary"},{id:"102072",title:"Dr.",name:"Andrei",middleName:null,surname:"Kochegarov",fullName:"Andrei Kochegarov",slug:"andrei-kochegarov"},{id:"102073",title:"Mrs.",name:"Sharon L.",middleName:null,surname:"Lemanski",fullName:"Sharon L. Lemanski",slug:"sharon-l.-lemanski"}]},{id:"35992",title:"Structural and Activity Changes in Renal Betaine Aldehyde Dehydrogenase Caused by Oxidants",slug:"impact-of-oxidants-on-the-activity-structure-and-conformational-stability-of-renal-betaine-aldehyde",totalDownloads:2083,totalCrossrefCites:0,signatures:"Jesús A. Rosas-Rodríguez, Hilda F. Flores-Mendoza, Ciria G. Figueroa-Soto, Edgar F. Morán-Palacio and Elisa M. Valenzuela-Soto",authors:[{id:"96690",title:"Dr.",name:"Elisa",middleName:null,surname:"Valenzuela-Soto",fullName:"Elisa Valenzuela-Soto",slug:"elisa-valenzuela-soto"},{id:"99831",title:"Dr.",name:"Jesús A.",middleName:null,surname:"Rosas-Rodríguez",fullName:"Jesús A. Rosas-Rodríguez",slug:"jesus-a.-rosas-rodriguez"},{id:"99832",title:"MSc.",name:"Ciria G.",middleName:null,surname:"Figueroa-Soto",fullName:"Ciria G. Figueroa-Soto",slug:"ciria-g.-figueroa-soto"},{id:"102874",title:"MSc.",name:"Hilda F.",middleName:null,surname:"Flores-Mendoza",fullName:"Hilda F. Flores-Mendoza",slug:"hilda-f.-flores-mendoza"},{id:"139474",title:"Dr.",name:"Edgar",middleName:null,surname:"Morán-Palacio",fullName:"Edgar Morán-Palacio",slug:"edgar-moran-palacio"}]},{id:"35993",title:"Signalling Oxidative Stress in Saccharomyces cerevisiae",slug:"signalling-the-oxidative-stress-in-saccharomyces-cerevisiae",totalDownloads:2224,totalCrossrefCites:0,signatures:"Maria Angeles de la Torre-Ruiz, Luis Serrano, Mima I. Petkova and Nuria Pujol-Carrion",authors:[{id:"98463",title:"Prof.",name:"Maria Angeles",middleName:null,surname:"De La Torre-Ruiz",fullName:"Maria Angeles De La Torre-Ruiz",slug:"maria-angeles-de-la-torre-ruiz"},{id:"102988",title:"Prof.",name:"Luis",middleName:null,surname:"Serrano",fullName:"Luis Serrano",slug:"luis-serrano"},{id:"102990",title:"Dr.",name:"Nuria",middleName:null,surname:"Pujol-Carrion",fullName:"Nuria Pujol-Carrion",slug:"nuria-pujol-carrion"},{id:"103002",title:"Mrs.",name:"Mima",middleName:null,surname:"Petkova",fullName:"Mima Petkova",slug:"mima-petkova"}]},{id:"35994",title:"Role of the Yap Family in the Transcriptional Response to Oxidative Stress in Yeasts",slug:"role-of-the-yap-family-the-transcriptional-response-to-oxidative-stress-in-yeasts",totalDownloads:1637,totalCrossrefCites:0,signatures:"Christel Goudot, Frédéric Devaux and Gaëlle Lelandais",authors:[{id:"94555",title:"Dr.",name:"Gaëlle",middleName:null,surname:"Lelandais",fullName:"Gaëlle Lelandais",slug:"gaelle-lelandais"}]},{id:"35995",title:"The Yeast Genes ROX1, IXR1, SKY1 and Their Effect upon Enzymatic Activities Related to Oxidative Stress",slug:"the-yeasts-genes-rox1-ixr1-sky1-and-their-effect-upon-enzymatic-activities-related-to-oxidative-st",totalDownloads:1964,totalCrossrefCites:0,signatures:"Ana García Leiro, Silvia Rodríguez Lombardero, Ángel Vizoso Vázquez, M. Isabel González Siso and M. Esperanza Cerdán",authors:[{id:"98916",title:"Prof.",name:"Maria Esperanza",middleName:null,surname:"Cerdan",fullName:"Maria Esperanza Cerdan",slug:"maria-esperanza-cerdan"},{id:"98926",title:"Dr.",name:"María-Isabel",middleName:null,surname:"González-Siso",fullName:"María-Isabel González-Siso",slug:"maria-isabel-gonzalez-siso"},{id:"102332",title:"Dr.",name:"Ana",middleName:null,surname:"García Leiro",fullName:"Ana García Leiro",slug:"ana-garcia-leiro"},{id:"102334",title:"MSc.",name:"Silvia",middleName:null,surname:"Rodríguez-Lombardero",fullName:"Silvia Rodríguez-Lombardero",slug:"silvia-rodriguez-lombardero"},{id:"102336",title:"Dr.",name:"Ángel",middleName:null,surname:"Vizoso-Vázquez",fullName:"Ángel Vizoso-Vázquez",slug:"angel-vizoso-vazquez"}]},{id:"35996",title:"Complex Regulatory Interplay Between Multidrug Resistance and Oxidative Stress Response in Yeast: The FLR1 Regulatory Network as a Systems Biology Case-Study",slug:"complex-regulatory-interplay-between-multidrug-resistance-and-oxidative-stress-response-in-yeast-th",totalDownloads:1822,totalCrossrefCites:0,signatures:"Miguel C. Teixeira",authors:[{id:"16150",title:"Dr.",name:"Miguel",middleName:null,surname:"Teixeira",fullName:"Miguel Teixeira",slug:"miguel-teixeira"}]},{id:"35997",title:"ROS as Signaling Molecules and Enzymes of Plant Response to Unfavorable Environmental Conditions",slug:"ros-as-a-signaling-molecules-and-enzymes-of-plant-response-to-unfavorable-environmental-conditions",totalDownloads:5133,totalCrossrefCites:5,signatures:"Dominika Boguszewska and Barbara Zagdańska",authors:[{id:"96271",title:"MSc",name:"Dominika",middleName:null,surname:"Boguszewska",fullName:"Dominika Boguszewska",slug:"dominika-boguszewska"},{id:"106525",title:"Prof.",name:"Brabara",middleName:null,surname:"Zagdańska",fullName:"Brabara Zagdańska",slug:"brabara-zagdanska"}]}]},relatedBooks:[{type:"book",id:"2134",title:"Oxidative Stress and Diseases",subtitle:null,isOpenForSubmission:!1,hash:"dfa7002beaf617a62594a235a9fe5dfd",slug:"oxidative-stress-and-diseases",bookSignature:"Volodymyr I. Lushchak and Dmytro V. Gospodaryov",coverURL:"https://cdn.intechopen.com/books/images_new/2134.jpg",editedByType:"Edited by",editors:[{id:"96151",title:"Dr.",name:"Volodymyr",surname:"Lushchak",slug:"volodymyr-lushchak",fullName:"Volodymyr Lushchak"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"35940",title:"Introductory Chapter",slug:"introduction-chapter",signatures:"Volodymyr I. Lushchak and Dmytro V. Gospodaryov",authors:[{id:"96151",title:"Dr.",name:"Volodymyr",middleName:"I",surname:"Lushchak",fullName:"Volodymyr Lushchak",slug:"volodymyr-lushchak"}]},{id:"35941",title:"Oxidative Stress: Cause and Consequence of Diseases",slug:"oxidative-stress-as-a-cause-and-consequence-of-diseases",signatures:"Dmytro Gospodaryov and Volodymyr Lushchak",authors:[{id:"96151",title:"Dr.",name:"Volodymyr",middleName:"I",surname:"Lushchak",fullName:"Volodymyr Lushchak",slug:"volodymyr-lushchak"},{id:"115540",title:"Dr.",name:"Dmytro V.",middleName:null,surname:"Gospodaryov",fullName:"Dmytro V. Gospodaryov",slug:"dmytro-v.-gospodaryov"}]},{id:"35942",title:"Reactive Oxygen Species and Cardiovascular Diseases",slug:"reactive-oxygen-species-and-cardiovascular-diseases",signatures:"Vitor Engrácia Valenti, Luiz Carlos de Abreu, Celso Ferreira and Paulo H. N. Saldiva",authors:[{id:"29595",title:"Prof.",name:"Paulo Hilario",middleName:null,surname:"Saldiva",fullName:"Paulo Hilario Saldiva",slug:"paulo-hilario-saldiva"},{id:"91784",title:"Dr.",name:"Vitor",middleName:"E.",surname:"Valenti",fullName:"Vitor Valenti",slug:"vitor-valenti"},{id:"92422",title:"Dr.",name:"Luiz Carlos",middleName:null,surname:"De Abreu",fullName:"Luiz Carlos De Abreu",slug:"luiz-carlos-de-abreu"},{id:"92426",title:"Dr.",name:"Celso",middleName:null,surname:"Ferreira",fullName:"Celso Ferreira",slug:"celso-ferreira"}]},{id:"35943",title:"Oxidative Stress in the Carotid Body: Implications for the Cardioventilatory Alterations Induced by Obstructive Sleep Apnea",slug:"oxidative-stress-in-the-carotid-body-implications-for-the-cardioventilatory-alterations-induced-by",signatures:"Rodrigo Iturriaga and Rodrigo Del Rio",authors:[{id:"91823",title:"Dr.",name:"Rodrigo",middleName:null,surname:"Iturriaga",fullName:"Rodrigo Iturriaga",slug:"rodrigo-iturriaga"},{id:"100459",title:"Dr.",name:"Rodrigo",middleName:null,surname:"Del Rio",fullName:"Rodrigo Del Rio",slug:"rodrigo-del-rio"}]},{id:"35944",title:"Adipocytokines, Oxidative Stress and Impaired Cardiovascular Functions",slug:"adipocytokines-oxidative-stress-and-impaired-cardiovascular-functions",signatures:"Ana Bertha Zavalza Gómez, María Cristina Islas Carbajal and Ana Rosa Rincón Sánchez",authors:[{id:"84149",title:"Dr.",name:"Ana Rosa",middleName:null,surname:"Rincon Sanchez",fullName:"Ana Rosa Rincon Sanchez",slug:"ana-rosa-rincon-sanchez"},{id:"92139",title:"Dr.",name:"Ana Bertha",middleName:null,surname:"Zavalza Gomez",fullName:"Ana Bertha Zavalza Gomez",slug:"ana-bertha-zavalza-gomez"},{id:"317056",title:"Prof.",name:"María Cristina",middleName:null,surname:"Islas-Carbajal",fullName:"María Cristina Islas-Carbajal",slug:"maria-cristina-islas-carbajal"}]},{id:"35945",title:"Role of Oxidized Lipids in Atherosclerosis",slug:"role-of-oxidized-lipids-in-atherosclerosis",signatures:"Mahdi Garelnabi, Srikanth Kakumanu and Dmitry Litvinov",authors:[{id:"88368",title:"Prof.",name:"Mahdi",middleName:null,surname:"Garelnabi",fullName:"Mahdi Garelnabi",slug:"mahdi-garelnabi"},{id:"105584",title:"Dr.",name:"Dmitry",middleName:null,surname:"Litvinov",fullName:"Dmitry Litvinov",slug:"dmitry-litvinov"},{id:"138421",title:"Dr.",name:"Srikanth",middleName:null,surname:"Kakumanu",fullName:"Srikanth Kakumanu",slug:"srikanth-kakumanu"}]},{id:"35946",title:"Oxidative Damage in Cardiac Tissue from Normotensive and Spontaneously Hypertensive Rats: Effect of Ageing",slug:"oxidative-damage-in-cardiac-tissue-from-normotensive-and-spontaneously-hypertensive-rats-effect-of",signatures:"Juliana C. Fantinelli, Claudia Caldiz, María Cecilia Álvarez, Carolina D. Garciarena, Gladys E. Chiappe de Cingolani and Susana M. Mosca",authors:[{id:"98613",title:"Dr.",name:"Susana",middleName:null,surname:"Mosca",fullName:"Susana Mosca",slug:"susana-mosca"}]},{id:"35947",title:"Oxidative Stress and Mitochondrial Dysfunction in Cardiovascular Diseases",slug:"oxidative-stress-and-mitochondrial-dysfunction-in-cardiovascular-diseases",signatures:"Sauri Hernández-Reséndiz, Mabel Buelna-Chontal, Francisco Correa and Cecilia Zazueta",authors:[{id:"102566",title:"Dr.",name:"Cecilia",middleName:null,surname:"Zazueta",fullName:"Cecilia Zazueta",slug:"cecilia-zazueta"},{id:"102568",title:"BSc.",name:"Sauri",middleName:null,surname:"Hernández-Reséndiz",fullName:"Sauri Hernández-Reséndiz",slug:"sauri-hernandez-resendiz"},{id:"102569",title:"BSc.",name:"Mabel",middleName:null,surname:"Buelna-Chontal",fullName:"Mabel Buelna-Chontal",slug:"mabel-buelna-chontal"},{id:"102570",title:"Dr.",name:"Francisco",middleName:null,surname:"Correa",fullName:"Francisco Correa",slug:"francisco-correa"}]},{id:"35948",title:"Oxidatively Modified Biomolecules: An Early Biomarker for Acute Coronary Artery Disease",slug:"oxidative-modified-biomolecules-an-early-biomarker-for-acute-coronary-artery-disease",signatures:"Sarawut Kumphune",authors:[{id:"91750",title:"Dr.",name:"Sarawut",middleName:null,surname:"Kumphune",fullName:"Sarawut Kumphune",slug:"sarawut-kumphune"}]},{id:"35949",title:"Oxidative Stress in Diabetes Mellitus: Is There a Role for Hypoglycemic Drugs and/or Antioxidants?",slug:"oxidative-stress-in-diabetes-mellitus-is-there-a-role-for-hypoglycemic-drugs-and-or-antioxidants",signatures:"Omotayo O. Erejuwa",authors:[{id:"92521",title:"Dr.",name:"Omotayo",middleName:null,surname:"Erejuwa",fullName:"Omotayo Erejuwa",slug:"omotayo-erejuwa"}]},{id:"35950",title:"Oxidative Stress and Novel Antioxidant Approaches to Reduce Diabetic Complications",slug:"oxidative-stress-and-novel-antioxidant-approaches-to-reduce-diabetic-complications",signatures:"Sih Min Tan, Arpeeta Sharma and Judy B. de Haan",authors:[{id:"102631",title:"Dr.",name:"Judy",middleName:null,surname:"De Haan",fullName:"Judy De Haan",slug:"judy-de-haan"}]},{id:"35951",title:"Evaluation of Oxidative Stress and the Efficacy of Antioxidant Treatment in Diabetes Mellitus",slug:"evaluation-of-oxidative-stress-and-the-efficacy-of-antioxidant-treatment-in-diabetes-mellitus",signatures:"Nemes-Nagy Enikő, V. Balogh-Sămărghiţan, Elena Cristina Crăciun, R. Morar, Dana Liana Pusta, Fazakas Zita, Szőcs-Molnár Terézia, Dunca Iulia, Sánta Dóra and Minodora Dobreanu",authors:[{id:"102559",title:"Dr.",name:"Eniko",middleName:null,surname:"Nemes-Nagy",fullName:"Eniko Nemes-Nagy",slug:"eniko-nemes-nagy"}]},{id:"35952",title:"Diabetes, Oxidative Stress, Antioxidants and Saliva: A Review",slug:"diabetes-oxidative-stress-antioxidants-and-saliva",signatures:"Natheer H. Al-Rawi",authors:[{id:"98868",title:"Dr.",name:"Natheer Hashim",middleName:null,surname:"Al-Rawi",fullName:"Natheer Hashim Al-Rawi",slug:"natheer-hashim-al-rawi"}]},{id:"35953",title:"The Role of Oxidative Stress in Female Reproduction and Pregnancy",slug:"the-role-of-oxidative-stress-in-female-reproduction-and-pregnancy",signatures:"Levente Lázár",authors:[{id:"91791",title:"Dr.",name:"Levente",middleName:null,surname:"Lazar",fullName:"Levente Lazar",slug:"levente-lazar"}]},{id:"35954",title:"Effects of Oxidative Stress on the Electrophysiological Function of Neuronal Membranes",slug:"effects-of-oxidative-stress-on-the-electrophysiological-function-of-neuronal-membranes",signatures:"Zorica Jovanović",authors:[{id:"96227",title:"Prof.",name:"Zorica",middleName:null,surname:"Jovanovic",fullName:"Zorica Jovanovic",slug:"zorica-jovanovic"}]},{id:"35955",title:"Circulating Advanced Oxidation Protein Products, Nε-(Carboxymethyl) Lysine and Pro-Inflammatory Cytokines in Patients with Liver Cirrhosis: Correlations with Clinical Parameters",slug:"circulating-advanced-oxidation-protein-products-and-pro-inflammatory-cytokines-in-patients-with-live",signatures:"Jolanta Zuwala-Jagiello, Eugenia Murawska-Cialowicz and Monika Pazgan-Simon",authors:[{id:"91914",title:"Associate Prof.",name:"Jolanta",middleName:null,surname:"Zuwala-Jagiello",fullName:"Jolanta Zuwala-Jagiello",slug:"jolanta-zuwala-jagiello"}]},{id:"35956",title:"Oxidative Stress in Parkinson's Disease; Parallels Between Current Animal Models, Human Studies and Cells",slug:"oxidative-stress-in-parkinson-s-disease-parallels-between-current-animal-models-human-studies-a",signatures:"Anwar Norazit, George Mellick and Adrian C. B. Meedeniya",authors:[{id:"95641",title:"Dr.",name:"Adrian",middleName:"C.B",surname:"Meedeniya",fullName:"Adrian Meedeniya",slug:"adrian-meedeniya"},{id:"102891",title:"Dr.",name:"George",middleName:null,surname:"Mellick",fullName:"George Mellick",slug:"george-mellick"},{id:"102895",title:"Mr.",name:"Anwar",middleName:null,surname:"Norazit",fullName:"Anwar Norazit",slug:"anwar-norazit"}]},{id:"35957",title:"The Relationship Between Thyroid States, Oxidative Stress and Cellular Damage",slug:"the-relationship-between-thyroid-states-oxidative-stress-and-cellular-damage",signatures:"Cano-Europa, Blas-Valdivia Vanessa, Franco-Colin Margarita and Ortiz-Butron Rocio",authors:[{id:"91909",title:"Prof.",name:"Edgar",middleName:null,surname:"Cano-Europa",fullName:"Edgar Cano-Europa",slug:"edgar-cano-europa"},{id:"102920",title:"Dr.",name:"Rocio",middleName:null,surname:"Ortiz-Butron",fullName:"Rocio Ortiz-Butron",slug:"rocio-ortiz-butron"},{id:"114461",title:"Prof.",name:"Vanessa",middleName:null,surname:"Blas-Valdivia",fullName:"Vanessa Blas-Valdivia",slug:"vanessa-blas-valdivia"},{id:"114462",title:"Prof.",name:"Adelaida",middleName:null,surname:"Hernández-García",fullName:"Adelaida Hernández-García",slug:"adelaida-hernandez-garcia"},{id:"114464",title:"Prof.",name:"Margarita",middleName:null,surname:"Franco-Colin",fullName:"Margarita Franco-Colin",slug:"margarita-franco-colin"}]},{id:"35958",title:"Oxidative Stress in Human Autoimmune Joint Diseases",slug:"oxidative-stress-in-human-autoimmune-joint-diseases",signatures:"Martina Škurlová",authors:[{id:"95645",title:"Ph.D.",name:"Martina",middleName:null,surname:"Skurlova",fullName:"Martina Skurlova",slug:"martina-skurlova"}]},{id:"35959",title:"Oxidative Stress in Multiple Organ Damage in Hypertension, Diabetes and CKD, Mechanisms and New Therapeutic Possibilities",slug:"oxidative-stress-in-multiple-organ-damage-in-hypertension-diabetes-and-ckd-mechanisms-and-new-ther",signatures:"Tatsuo Shimosawa, Tomoyo Kaneko, Xu Qingyou, Yusei Miyamoto, Mu Shengyu, Hong Wang, Sayoko Ogura, Rika Jimbo, Bohumil Majtan, Yuzaburo Uetake, Daigoro Hirohama, Fumiko Kawakami-Mori, Toshiro Fujita and Yutaka Yatomi",authors:[{id:"95564",title:"Dr.",name:null,middleName:null,surname:"Shimosawa",fullName:"Shimosawa",slug:"shimosawa"}]},{id:"35960",title:"Retinal Vein Occlusion Induced by a MEK Inhibitor - Impact of Oxidative Stress on the Blood-Retinal Barrier",slug:"oxidative-stress-and-retinal-vein-occlusion",signatures:"Amy H. Yang and Wenhu Huang",authors:[{id:"107126",title:"Dr.",name:"Wenhu",middleName:null,surname:"Huang",fullName:"Wenhu Huang",slug:"wenhu-huang"},{id:"107129",title:"Dr.",name:"Amy",middleName:null,surname:"Yang",fullName:"Amy Yang",slug:"amy-yang"}]},{id:"35961",title:"Oxidative Therapy Against Cancer",slug:"oxidative-therapy-against-cancer",signatures:"Manuel de Miguel and Mario D. Cordero",authors:[{id:"67123",title:"Dr.",name:"Mario D.",middleName:null,surname:"Cordero",fullName:"Mario D. Cordero",slug:"mario-d.-cordero"},{id:"77269",title:"Mr.",name:"Manuel",middleName:null,surname:"De Miguel",fullName:"Manuel De Miguel",slug:"manuel-de-miguel"}]},{id:"35962",title:"Monensin Induced Oxidative Stress Reduces Prostate Cancer Cell Migration and Cancer Stem Cell Population",slug:"prostate-cancer-cell-migration-and-cancer-stem-cell-population-is-reduced-via-oxidative-stress-induc",signatures:"Kirsi Ketola, Anu Vuoristo, Matej Orešič, Olli Kallioniemi and Kristiina Iljin",authors:[{id:"101326",title:"Dr.",name:"Kristiina",middleName:null,surname:"Iljin",fullName:"Kristiina Iljin",slug:"kristiina-iljin"}]},{id:"35963",title:"Compounds with Antioxidant Capacity as Potential Tools Against Several Oxidative Stress Related Disorders: Fact or Artifact?",slug:"compounds-with-antioxidant-capacity-as-potential-tools-against-several-oxidative-stress-related-diso",signatures:"P. Pérez-Matute, A.B. Crujeiras, M. Fernández-Galilea and P. Prieto-Hontoria",authors:[{id:"105894",title:"Dr.",name:"Patricia",middleName:null,surname:"Perez-Matute",fullName:"Patricia Perez-Matute",slug:"patricia-perez-matute"}]},{id:"35964",title:"Microalgae of the Chlorophyceae Class: Potential Nutraceuticals Reducing Oxidative Stress Intensity and Cellular Damage",slug:"the-microalgae-of-the-chlorophyceae-class-have-potential-as-nutraceuticals-because-their-ingestion-r",signatures:"Blas-Valdivia Vanessa, Ortiz-Butron Rocio, Rodriguez-Sanchez Ruth, Torres-Manzo Paola, Hernandez-Garcia Adelaida and Cano-Europa Edgar",authors:[{id:"91909",title:"Prof.",name:"Edgar",middleName:null,surname:"Cano-Europa",fullName:"Edgar Cano-Europa",slug:"edgar-cano-europa"},{id:"102920",title:"Dr.",name:"Rocio",middleName:null,surname:"Ortiz-Butron",fullName:"Rocio Ortiz-Butron",slug:"rocio-ortiz-butron"},{id:"114462",title:"Prof.",name:"Adelaida",middleName:null,surname:"Hernández-García",fullName:"Adelaida Hernández-García",slug:"adelaida-hernandez-garcia"},{id:"129676",title:"Prof.",name:"Vanessa",middleName:null,surname:"Blas-Valdivia",fullName:"Vanessa Blas-Valdivia",slug:"vanessa-blas-valdivia"},{id:"129677",title:"M.Sc.",name:"Rodriguez-Sanchez",middleName:null,surname:"Ruth",fullName:"Rodriguez-Sanchez Ruth",slug:"rodriguez-sanchez-ruth"},{id:"129678",title:"MSc.",name:"Paola",middleName:null,surname:"Torres-Manzo",fullName:"Paola Torres-Manzo",slug:"paola-torres-manzo"}]}]}]},onlineFirst:{chapter:{type:"chapter",id:"75042",title:"Micronutrient Antioxidants in the Chemoprevention of Breast Cancer and Effect on Breast Cancer Outcomes",doi:"10.5772/intechopen.95886",slug:"micronutrient-antioxidants-in-the-chemoprevention-of-breast-cancer-and-effect-on-breast-cancer-outco",body:'\nBreast cancer remains one of the most frequent cancers affecting women globally. In 2018, 2.1 million new cases were reported, accounting for approximately one in every four cases of cancer among women [1]. Breast cancer accounted for almost 15% of cancer-related deaths in women in 2018 [2]. It is more common in the developed world, with highest incidence in regions such as Europe and Northern America [1]. However, mortality rates are higher in developing regions such as Africa [1]. Breast cancer is linked to numerous risk factors including family history, gene mutations, obesity, hormonal therapy, and alcohol consumption [3] but a recognizable risk profile is not usually present in most women who develop the disease [4]. Even though curative therapy is promising following early detection, approximately 30% of cases diagnosed at early stages will progress to metastatic disease [5]. Furthermore, cases of disseminated disease are almost always untreatable and radical prophylactic mastectomy remains the only primary preventative measure [6]. These challenges have spawned a shift in the treatment paradigm of the disease, which has led to major treatment advancements and improved palliative care. However, drug resistance and adverse side effects are common nuisances of current therapy [7]. Therefore, new approaches to breast cancer management with treatments that have minimal harmful effects and can retard tumor progression are required.
\nTo determine effective treatment approaches for breast cancer, it may be worthwhile to elucidate the complexity of the tumor microenvironment. It has been suggested that impaired mitochondrial metabolism may be a feature of tumor progression [8]. Additionally, it has been reported that a hallmark feature of mitochondrial dysfunction is the generation of reactive oxygen species (ROS) which may cause pro-tumorigenic outcomes such as DNA damage and genomic instability [8]. Reactive oxygen species include molecules such as superoxide anion, hydrogen peroxide, hydroxyl radical and singlet oxygen. They are involved in cell signaling through second messenger pathways in both cancer cells and their normal counterparts [9]. It was reported that various cancers are characterized by overproduction of ROS that can increase pro-tumorigenic signaling, cell survival and DNA aberrations [10]. Similarly, another study reported that elevated ROS levels is necessary to support and sustain metastasis [11].
\nOxidative stress is widely considered to play a major role in the initiation and pathogenesis of breast cancer [12]. It refers to the imbalance between ROS production and clearance favoring decreased clearance and a pro-oxidant environment caused by either an overproduction of ROS or decreased antioxidant activity [13]. In breast cancer, a vast majority of stromal fibroblasts becomes activated following exposure to oxidative stress resulting in hydrogen peroxide production which triggers tumorigenic changes in breast epithelial cells [12]. A plethora of high energy nutrients and growth factors are also produced which fuels metastasis [12]. Congruently, it was reported that higher levels of oxidative stress biomarkers such as malondialdehyde and oxidized glutathione were found in breast cancer patients compared to control subjects [14]. The human body comprises an antioxidant defense system which exerts its function by generating antioxidants including the catalases, glutathione peroxidases and superoxide dismutase which offer protective effects by metabolizing and scavenging free radicals to inhibit and minimize tissue damage [15]. It is important to note that despite the presence of an endogenous antioxidant system, DNA damage ensues and accumulates throughout life and could considerably contribute to the initiation and progression of cancers [16]. Given the accumulation of evidence supporting the role of ROS in the pathogenesis of breast cancer, there is a possibility that dietary micronutrient antioxidants may be useful to counteract oxidative stress induced cancer. Moreover, it was reported that antioxidant supplement use among breast cancer patients was 45–80% [17].
\nThis paper will review information in the literature on the relationship between dietary and supplement micronutrient antioxidants including vitamins C and E and their association with the risk of breast cancer as well as outcomes such as disease recurrence and mortality.
\nA literature search was conducted for all English language literature published before December 2020. The search was conducted using the electronic databases, including PubMed, Embase, Web of Science, and Cochrane Library. The search strategy included keywords such as breast cancer, epidemiology, incidence, risk, recurrence, mortality, vitamin E, vitamin C, carotenoids, flavonoids and green tea. The authors include many interventional and observational studies that have reported findings of dietary and supplemental micronutrient antioxidants, breast cancer incidence, and progression. The majority of these studies focused on vitamins E and C, carotenoids, specifically beta- and alpha-carotene, lycopene as well as the flavonoids, flavonols and isoflavones.
\nVitamin C is a naturally occurring essential micronutrient that is soluble in water and its antioxidant properties involve neutralizing reactive oxygen species as well as other free radicals [18]. Investigational experiments and epidemiologic findings on vitamin C and breast cancer risk are still inconclusive and reviews of data have suggested both detrimental and protective effects on overall risk of breast cancer [19]. Prospective studies on vitamin C intake and breast cancer risk have yielded diverse findings [20–23]. A recent meta-analysis reported that dietary vitamin C but not supplements was associated with a lesser risk of breast cancer incidence (RR = 0.89; 95% CI: 0.82–0.96) [20]. In the European Prospective Investigation into Cancer and Nutrition Study of 7,502 primary invasive breast cancer cases with a median follow-up time of approximately 9 years, multivariate analyses showed that vitamin E and C were not related with breast cancer risk in postmenopausal and premenopausal women. However, high intake of vitamin C was associated with decreased breast cancer risk in postmenopausal women utilizing exogenous hormones [21]. Earlier, in the Netherlands Cohort Study comprising of 62,573 women with 650 incident breast cancer cases identified after a follow-up of 4.3 years, dietary Vitamin E and vitamin C supplement use did not influence breast cancer risk, but there a small reduction in risk with increasing dietary intake of vitamin C particularly at the highest quintile [22]. Correspondingly, findings from the Women’s Health Initiative Observational Study which followed 84,805 women for approximately 8 years with 2,879 incident invasive cancer cases ascertained, showed a weak positive association of breast cancer risk with total and supplemental vitamin C particularly among postmenopausal women (Table 1) [23].
\nVitamin/Micro-nutrient (antioxidant) | \nReference | \nStudy design | \nPopulation (Case, participants) | \nExposure | \nRisk estimates (95% CI) | \nOutcome | \n
---|---|---|---|---|---|---|
Vitamin C and E | \n\n29\n | \nCase–control | \n297 breast cancer cases and 311 controls | \nDietary vitamin C | \nVitamin C: OR = 0.53 (0.33–0.86) Vitamin E: OR = 0.55 (0.34–0.88) | \nReduction by 47% (mainly in premenopausal women) Reduction by 45% | \n
Lycopene | \n\n150\n | \nCase–control | \n46 breast cancer cases and 63 controls | \nLycopene in adipose tissue | \nOR = 0.32 (0.11–0.94) | \nReduction by 68% | \n
Vitamin E | \n\n29\n | \nCase–control | \n297 breast cancer cases and 311 controls | \nDietary vitamin E | \nOR = 0.55 (0.34–0.88) | \nReduction by 45% | \n
Vitamin E | \n\n53\n | \nPopulation-based case–control | \n2,362 breast cancer cases and 2,462 controls | \nVitamin E (supplement) | \nOR = 0.75 (0.58–0.97) | \nReduction by 25% | \n
Alpha-carotene and beta-carotene | \n\n90\n | \nPopulation-based case–control | \n5,707 women with incident invasive breast cancer | \nAlpha-carotene and beta-carotene (supplement) | \nAlpha-carotene OR = 0.82 (0.68–0.98; Ptrend = 0.07) Beta-carotene OR = 0.81 (0.68–0.98; Ptrend = 0.009) | \nReduction by 18% for premenopausal women Reduction by 19% for premenopausal women | \n
Alpha-carotene and beta-carotene | \n\n23\n | \nWomen’s Health Initiative Observational Study | \n84,805 women followed for average 7.6 yrs. | \nAlpha-carotene and beta-carotene (supplement) | \nAlpha-carotene RR = 0.83 (0.70–0.99, Ptrend = 0.019). Beta-carotene RR = 0.78 (0.66–0.94, Ptrend = 0.021) | \nReduction by 17% (highest vs. lowest quintile) Reduction by 22% (highest vs. lowest quintile) | \n
Total flavonoids and flavonols | \n\n110\n | \nCase–control | \n1522 breast cancer cases and 1547 controls | \nDietary total flavonoids and flavonols | \nTotal flavonoids: OR = 0.66 (0.54–0.82) Flavonols: OR = 0.51 (0.41–0.63) | \nReduction by 34% Reduction by 49% | \n
Flavones and flavonols | \n\n112\n | \nCase–control | \n1,434 breast cancer cases and 1,440 controls | \nDietary flavones and flavonols | \nFlavones: OR = 0.61, (0.45–0.83) Flavonols: OR = 0.54 (0.40–0.73) | \nReduction by 39% Reduction by 46% | \n
Soy isoflavones | \n\n129\n | \nThe Shanghai Breast Cancer Survival Study (prospective) | \n4,139 stage 0 –III breast cancer patients and 1987 pre−/perimenopausal and 2152 postmenopausal patients | \nDietary soy isoflavones | \nHR = 0.22, (0.09–0.53) | \nReduction by 78% in premenopausal women (high intake) | \n
Lycopene and beta-carotene | \n\n93\n | \nCase–control | \n122 breast cancer cases and 632 healthy controls | \nDietary lycopene and beta-carotene | \nLycopene: Adjusted OR = 0.26, (0.14–0.46) Beta-carotene: Adjusted OR = 0.43 (0.23–0.82) | \nReduction by 74% Reduction by 57% | \n
Summary of selected studies that provide risk estimates of the associations between dietary and supplemental vitamins and micronutrients (antioxidants) and breast cancer risk.
Other prospective studies showed increased breast cancer risk with dietary or supplemental vitamin C. Using a large cohort of 2,482 invasive breast cancer cases in 57,403 postmenopausal Women, Cadeau et al. examine the association between vitamin C supplement use and breast cancer risk while bearing in mind dietary vitamin C intake, and found no relation with the overall risk, but females in the fourth quartile of vitamin C intake from foods had a 32% increase in breast cancer risk [24]. Published in 2011, a meta-analysis of 51 studies comparing highest with the lowest vitamin C intake from supplements may be associated with higher breast cancer risk [25], but it was noted that the overall result was influenced by a single large study [23]. In this same meta-analysis, dietary and total vitamin E, and dietary vitamin A significantly decreased breast cancer risk for cohort studies, but the results became nonsignificant when case–controlled studies were pooled [25]. Notably, Sharhar et al. examined relations between oxidative stress and antioxidant status in 57 newly diagnosed breast cancer cases and found poor antioxidant status as indicated by low plasma vitamin C which elevated by two to three times the breast cancer risk [26].
\nThe findings of reduced breast cancer incidence with vitamin C consumption was more evident in case–control studies. In Nurses’ Health Study involving a large cohort of 83,234 women where 2,697 incident cases of invasive breast cancer was identified after 14 years, the associations between vitamins A, C and E, fruit and vegetables, and specific carotenoids and breast cancer risk were examined. There was a weakly inverse association between dietary vitamin A and breast cancer risk in premenopausal women and strong inverse association with increasing quartiles of dietary vitamin C, alpha-carotene and beta-carotene among premenopausal women who had a positive family history of breast cancer [27]. Likewise, a case–control study conducted in Korea comprising 224 incident breast cancer cases and 250 matched controls establish that vitamin C and beta-carotene intake were associated with decreased breast cancer risk, thus possibly lowered incidence in Korean women [28]. Moreover, in an earlier case–control study of 297 breast cancer cases matched with 311 control subjects, there was a significant reduction in breast cancer risk with beta-carotene, alpha-tocopherol and vitamin C when the lowest quartile was used as reference and odds ratios adjusted for the highest quartile [29] (Table 1). Conversely, no evidence of association between dietary or total vitamin C intake and breast cancer risk in the UK Dietary Cohort Consortium pooled analysis involving a nested case–control study [30], nor between dietary and supplement vitamin C intake and breast cancer risk in a large prospective study of 89,494 women during eight years of follow-up [31].
\nCancer chemoprevention in vitro studies have demonstrated that vitamin C in pharmacological concentrations is cytotoxic to numerous type of cancer cells including ovarian and pancreatic while not affecting normal cells [32].
\nGlobally, there is increasing use of vitamins among cancer patients and in the UK Women’s Cohort Study comprising 12,453 females, there was self-reported frequently high dose vitamin C supplement intake use among breast cancer patients [33]. Furthermore, a number of epidemiologic studies have investigated the association between dietary vitamin C, vitamin C supplements and survival outcomes subsequent to breast cancer diagnosis. In a meta-analysis of prospective studies, post-diagnosis vitamin C supplement use was associated with decreased risk for breast cancer-specific (RR = 0.85, 95%CI: 0.74–0.99) and total mortality (RR = 0.81, 95%CI: 0.72–0.91) while dietary intake was also statistically significant for these two survival outcomes [34]. It was noted that in the Swedish Mammography Cohort Study comprising of 3,405 females with invasive breast cancer there was a marginal significant association between dietary vitamin C intake and all-cause mortality, but no association between supplement use subsequent to diagnosis and breast cancer-specific mortality [35].
\nNevertheless, the findings are not consistent with intake of dietary vitamin C stated to decrease mortality risk in some studies [36, 37], while no relation in other epidemiologic studies [38, 39, 40]. There are also other prospective studies, which have investigated the relationship between vitamin C supplement use and breast cancer survival [17, 41, 42], and recently there is a published meta-analysis of observational studies [20]. In this meta-analysis, pooled results from 69 studies, the hazard risk for all-cause mortality was 0.82 (95% CI: 0.74–0.91), breast cancer recurrence 0.81 (95% CI: 0.67–0.99) and breast cancer-specific mortality 0.78 (95% CI: 0.69–0.88) [20].
\nThere are apprehensions that supplement use, mainly antioxidants might decrease the cytotoxicity of chemotherapy and make it less operative [43]. Dietary antioxidant supplementation with radiation treatment and conventional chemotherapy have yielded conflicting results and many randomized clinical trials have reported deceased therapy-related side effects [44, 45]. There is data that attest to the protective effect of tumor cells as well as healthy cells by antioxidants since they neutralize reactive oxygen species and other free radical generated by some forms of chemotherapy and radiotherapy, thus reducing efficacy and ultimately survival [46, 47]. In the Breast Cancer Enrolled in a Cooperative Group Clinical Trial (SWOG S0221), Ambrosone et al. assessed associations between dietary antioxidant supplement (vitamins C, E and A as well as coenzyme Q and carotenoids) before and during chemotherapy (doxorubicin, paclitaxel and cyclophosphamide) treatment and survival outcomes. The use of any of the dietary supplements such as vitamin C resulted in a 41% higher hazard of recurrence of marginal significance, with a comparative but lesser association with mortality [48]. The authors suggested that patients should exercise caution when contemplating the use of supplement vitamin C during chemotherapy [48].
\nConversely, epidemiologic studies have demonstrated improved usefulness of numerous cancer therapeutic agents with less adverse side effects when administered concomitantly with antioxidants [49]. Interesting, in a recent study it was found that vitamin C increased the therapeutic window of bromodomain and extra-terminal inhibitors thereby improving their efficacy for treating patients with aggressive triple negative breast cancer [50].
\nThe role of dietary and vitamin E supplements in preventing breast cancer still remains unclear [51]. Previous research have demonstrated that there is a lack of any consistent association between vitamin E and the risk of breast cancer [52]. In a large population-based case–control study conducted in Canada that examined antioxidants intakes from diet and supplements and their potential breast cancer risk, 10 years or more supplementation with vitamin E was associated with reduced breast cancer risk (OR = 0.75, 95% CI: 0.58–0.97). However, no significant effect of dietary vitamin E intake or from supplementation less than 10 years was observed [53] (Table 1). Likewise, Fulan et al. conducted a meta-analysis of 51 studies on vitamin E intake and found that dietary vitamin E significantly decreased breast cancer risk, but there was no significant dose–response relationship in the higher intake of vitamin E [25]. An earlier case–control study comprising 297 breast cancer cases and 311 control subjects conducted in the United States found a significant reduction in breast cancer risk associated with high intake of dietary vitamin E (OR = 0.55; 95% CI: 0.34–0.88). However, no association was observed between vitamin E supplement intake and breast cancer risk [29]. Notably, findings from the Shanghai Breast Cancer Study suggests that vitamin E supplements may confer safeguard against breast cancer (OR = 0.80; 95%CI, 0.60–1.00) among Chinese women who had low dietary intake [54]. In addition, there were other studies that corroborated these finding including an inverse association of dietary vitamin E with breast cancer risk in a hospital-based case–control study of Chinese women [55] and vitamin E significantly decreased breast cancer risk in a case–control study comprising Greek women [56].
\nHowever, there are a number of prospective and case–control studies that reported no association between dietary and/or supplement vitamin E intake and breast cancer risk [22, 31, 57]. Verhoeven et al. reported findings from the Netherlands Cohort Study, a large prospective cohort research that examined the relationships between various vitamins, vegetables and fruits with breast cancer risk and found no strong evidence of dietary vitamin E intake in the etiology of breast cancer [22]. An earlier large prospective study found that large intake of dietary vitamin E did not protect from breast cancer (OR = 0.99, 95%CI: 0.83–1.19) [31]. Results from other studies on dietary or supplemental vitamin E intake demonstrated similar null association [58, 59]. These include: a case–control by Wang et al. that did not find any meaningful association of dietary vitamin E intake with breast cancer risk [60], no association of higher dietary intake of vitamin E (in early adult life) among postmenopausal women in the Nurses’ Health Study II [57], and meta-analysis of 26 studies that found no effect of vitamin E supplementation on breast cancer risk on reviewing data from five cohort and four case–control studies [61].
\nOver the last decade the use of antioxidant supplements after breast cancer diagnosis and during treatment significantly increased and has become quite common among survivors [53, 61]. In a review of the literature on non-herbal nutrition supplements use in relieving symptoms induced by chemotherapy or radiation treatment, Samuels et al. showed that a number of studies suggest that antioxidant supplements use comprising glutamine, vitamin E and acetyl-L-carnithine possibly might decrease the occurrence and severity of paclitaxel-induced neuropathy [62]. In a comprehensive review of the 22 prospective studies by Greenlee et al. in 2009 that examined the association between use of antioxidant supplements (vitamin E as well as multivitamins, vitamin C, antioxidant combinations, soy isoflavones, melatonin, glutathione, or glutamine) and patient outcomes, there were no single antioxidant supplement during conventional breast cancer therapy that had a significant effect on recurrence, tumor response, toxicities, or survival. The authors indicated that findings from limited studies proposed that vitamin E decrease the hot flashes in patients treated with hormonal therapy and glutamine for oral mucositis [17]. In a more recent study, Huang et al. assessed the associations of dietary intake of fish, fruit and vegetable supplemented with vitamins E and B, and post-therapy cognitive recovery in 1,047 patients with breast cancer enrolled in the Shanghai Breast Cancer Survival Study. Higher dietary intake and supplement use were associated with greater cognitive scores at 36 months post-diagnosis thus improvement in post-therapy mental recovery [63].
\nGlobally, the consumption of dietary supplements including vitamins and multivitamins/multi-minerals is increasing more so among females than males [64, 65]. However, there are only few studies that have examined vitamin E supplementation and survival outcomes in breast cancer patients. A well-designed prospective population-based prospective cohort study comprised of 4,877 females diagnosed with invasive breast cancer in China reported that vitamin E as well as multivitamin use were beneficial in improving survival and mortality rates. There was a 22% decreased recurrence risk and 18% lower mortality risk in females who use vitamin E supplement within 6 months after breast cancer diagnosis [42] (Table 2). Likewise, in the Life After Cancer Epidemiology (LACE) Study comprising of 2,264 females with early-stage breast cancer, 81% use antioxidants post-diagnosis. The regular use of vitamin E was concomitant with reduced risk of disease recurrence (HR = 0.71, 95%CI: 0.54–0.94) and diminished risk for all-cause mortality (HR = 0.76, 95%CI: 0.58–1.00) [41] (Table 2). Similarly, data from the After Breast Cancer Pooling Project showed that vitamin E was associated with reduced risk of breast cancer recurrence (RR = 0.88; 95%CI 0.79–0.99) [66]. The findings of a case–control study comprising 385 post-menopausal breast cancer patients performed in the United States corroborated previous reports as the use of antioxidant supplement (vitamins E or C, selenium or β-carotene) was associated with decreased breast cancer-specific death [37]. While these results suggest that antioxidants supplement use may have a protective effect and improve breast cancer survival, there were concerns of recall bias and the legitimacy of the exposure assessment. Furthermore, a recent systematic review and meta-analysis comprising randomized clinical trials and observational studies showed that vitamin E significantly reduced total mortality (RR = 0.76, 95% CI: 0.64–0.90) and breast cancer recurrence (RR = 0.69, 95% CI: 0.55–0.85) [67] (Table 3).
\nVitamin/Micro-nutrient (antioxidant) | \nReference | \nStudy design | \nPopulation (Case, participants) | \nExposure | \nRisk estimates (95% CI) | \nOutcome | \n
---|---|---|---|---|---|---|
Vitamin E, C and multivitamins | \n\n42\n | \nPopulation-based prospective cohort | \n4,877 women diagnosed with breast cancer (aged 20–75 yrs) | \nVitamin E, C and multivitamins | \nHR = 0.82 (0.65–1.02) for mortality HR = 0.78 (0.63–0.95) for risk of breast recurrence | \nReduction by 18% and 22% respectively | \n
Vitamin E and C | \n\n41\n | \nLife After Cancer Epidemiology (LACE) cohort | \n2,264 women with early stage breast cancer | \nVitamin E and C (supplement) | \n(i) Vitamin E: HR = 0.71 (0.54–0.94) for breast cancer recurrence and HR = 0.76 (0.58–1.00) for all-cause mortality Vitamin C: HR = 0.73 (0.55–0.97) for risk of breast cancer recurrence | \nReduction by 29% and 24% respectively Reduction by 27% | \n
Vitamin C and E | \n\n66\n | \nAfter Breast Cancer Pooling Project | \nFour cohorts of 12,019 breast cancer survivors | \nVitamin C and E (supplement) | \nVitamin C: RR = 0.81 (0.55–0.97) for all-cause mortality Vitamin E: RR = 0.88 (0.79–0.99) for risk of breast cancer recurrence | \nReduction by 19% Reduction by 12% | \n
Soy isoflavones or soy protein | \n\n143\n | \nThe Shanghai Breast Cancer Survival Study (a large, population-based cohort | \n5,042 female breast cancer survivors | \nSoy isoflavones or soy protein intake | \nHR = 0.68 (0.64–0.87) for risk of breast cancer recurrence (HR = 0.71 (0.54–0.92) for all-cause mortality (ER+ or ER- women) | \nReduction by 32% Reduction by 29% | \n
Soy isoflavonones | \n\n144\n | \nProspective | \n256 Chines women | \n\n | Soy isoflavones: OR = 0.25 (0.09–0.54) for breast cancer mortality | \nReduction by 75% | \n
Summary of selected studies that provide risk estimates of the associations between dietary and supplemental vitamins and micronutrients (antioxidants) and breast cancer outcomes such as recurrence and mortality.
Vitamin/Micro-nutrient (antioxidant) | \nReference | \nStudy design | \nPopulation (Case, participants) | \nExposure | \nRisk estimates (95% CI) | \nOutcome | \n
---|---|---|---|---|---|---|
Vitamin C | \n\n20\n | \nMeta-analysis | \n69 studies relevant to breast cancer risk (54 studies) and survival (15 studies) | \nDietary vitamin C | \nRR = 0.78 (0.69–0.88) for breast cancer-specific mortality; RR = 0.81 (0.67–0.99) for risk of breast cancer recurrence | \nReduction by 22% and 19% respectively | \n
Vitamin C | \n\n34\n | \nMeta-analysis | \n10 studies | \nSupplement vitamin C | \nRR = 0.81 (0.72–0.91) for total mortality & RR = 0.85 (0.74–0.99) for risk of breast cancer-specific mortality | \nReduction by 19% and 15% respectively | \n
Vitamin C and E | \n\n67\n | \nMeta-analysis | \nObservational studies and randomized clinical trials | \nVitamin C and E (supplement) | \nVitamin C: RR = 0.79 (0.68–0.92) for total mortality and RR = 0.76 (0.64–0.91) for risk of breast cancer recurrence Vitamin E: RR = 0.76 (0.64–0.90) for total mortality and RR = 0.69 (0.55–0.85) for risk of breast cancer recurrence | \nReduction by 21% and 24% respectively Reduction by 24% and 31% respectively | \n
Alpha carotene and beta-carotene | \n\n91\n | \nMeta-analysis | \n33 observational studies | \nDietary alpha carotene and beta-carotene | \nAlpha-carotene: RRpooled = 0.91 (0.85–0.8, P = 0.01) for breast cancer risk Beta-carotene RRpooled = 0.94 (0.88–1.00, P = 0.05)for breast cancer risk | \nReduction by 9% Reduction by 6% | \n
Soy isoflavones | \n\n135\n | \nMeta-analysis | \n\n35\n | \nSoy flavones intake | \nPremenopausal: OR = 0.59 (0.48–0.69) for breast cancer risk Postmenopausal women: OR = 0.59, (0.44–0.74) for breast cancer risk particularly in Asian women | \nReduction by 41% Reduction by 41% | \n
Soy isoflavones | \n\n146\n | \nMeta-analysis | \n18 studies | \nSoy isoflavones intake | \nRR = 0.89 (0.79–0.99) for risk of breast cancer incidence RR = 0.84 (0.70–0. 99) for risk of breast cancer recurrence | \nReduction by 11% Reduction by 16% | \n
Lutein/zeaxanthin | \n\n151\n | \nMeta-analysis | \n8 cohort studies | \nLutein/zeaxanthin | \nRR = 0.84 (0.70–1.01, Ptrend = 0.05) | \nReduction by 16% | \n
Quercetin | \n\n116\n | \nMeta-analysis | \n12 studies (6 prospective cohort and 6 case controls) | \nQuercetin intake | \nRR = 0.88 (0.80–0.98) | \nReduction by 12% | \n
Summary of selected meta-analysis and systematic reviews that provide risk estimates of the associations between dietary and supplemental vitamins and micronutrients (antioxidants) and breast cancer risk.
Despite over thirty years of research examining dietary antioxidant supplement use during radiation therapy and conservative chemotherapy, there are significant disagreements regarding the effectiveness of this complementary therapy [68, 69]. Encouraging results from many randomized control trials confirmed that the concomitant administration of supplementation antioxidants with radiation therapy and chemotherapy decreases side effects related to treatment [70]. However, some studies have suggested that antioxidant supplementation may guard malignant tumor cells from the pro-oxidant effects such as oxidative injury produced by chemotherapeutic agents and radiation treatment [71, 72].
\nThe quality of life and performance of normal daily activities can be negatively impacted by chemotherapy-induced peripheral neuropathy [73]. Using data from the Diet, Exercise, Lifestyle, and Cancer Prognosis (DELCaP) study, Zirpoli et al. reported that the use of multivitamins prior to diagnosis was associated with decreased symptoms of chemotherapy-induced peripheral neuropathy while use during therapy was slightly related with this outcome [74]. However, in a recent study, Jung et al. reported findings from the population-based Mamma Carcinoma Risk Factor Investigation (MARIE) study and noted that pre and post-diagnosis supplement use among of 2,223 postmenopausal women diagnosed with non-metastatic breast cancer was 36% and 45% respectively. The use of antioxidants throughout radiation therapy and chemotherapy was associated with higher total mortality risk (HR = 1.64; 95% CI: 1.01–2.66) and exacerbated recurrence-free survival (HR = 1.84; 95% CI: 1.26–2.68) [75]. The was also no relations between post-diagnosis use of supplement and disease prognosis, and the authors suggests that breast cancer patients should not use antioxidants during radiation therapy and chemotherapy [75].
\nThe natural activity of dietary and supplement antioxidants is due to a number of factors comprising the existing level of oxidative stress, collaborations of antioxidants, and the level of antioxidants present in cells [45]. The consumption of vitamin supplements among breast cancer patients post-diagnosis is quite common [76]. There are prospective studies that have demonstrated that multivitamin consumption improve survival rates in breast cancer patients [66, 77]. In the After Breast Cancer Pooling Project, Poole et al. examined the associations between post-diagnosis supplement use (multivitamins, vitamin E, D, C and B) and survival outcomes such as breast cancer-specific mortality, total disease mortality and risk of breast cancer recurrence in four cohorts of 12,019 patients in China and the United States. Using multivariate models, antioxidant supplement use (multivitamins, vitamin E or, C) was associated with improved survival as there was a 16% reduced risk of total mortality but not related with disease recurrence [66]. The findings of the Life After Cancer Epidemiology study that comprised of 2,236 women diagnosed with early-stage breast cancer indicate that multivitamin use may be valuable in improving breast cancer outcomes as frequent use prior to and after diagnosis was associated with non-significant reduced death from any cause and disease recurrence. In addition, the protective effect was for only breast cancer survivors treated by both radiation and chemotherapy, and radiation only and those who ate more fruits and vegetable and engaged in physical exercise had improved overall survival [77]. Notably, a recent systematic review and meta-analysis comprising randomized clinical trials and observational studies reported that multivitamin use lower breast cancer recurrence, and these findings were mostly based on observational studies while more randomized clinical trials are required to justify any recommendation for the dietary supplement use [67].
\nConversely, in a large retrospective cohort study of breast cancer patients belonging to the British Columbia Cancer Agency followed for 68 months, an administered regimen mega-dose vitamin/mineral supplements non-significantly increase the hazard ratios for disease-free survival and breast cancer-specific mortality. However, limitations include absence of critical information on use of over-the-counter vitamins, treatment compliance and possible selection bias [78]. Moreover, in a multicenter study of 3,081 early-stage breast cancer patients, although dietary supplement users had acceptable intakes of micronutrients, vitamin use and mineral intake was not concomitant with all-cause mortality.
\nEpidemiologic studies have suggested that increased fruit and vegetable intake is associated with lower risk of breast cancer [79]. Supporting evidence is provided by findings from a pooled analysis of eight prospective cohort studies where total fruit and vegetable intake was associated with decreased breast cancer risk (RR = 0.93, 95% CI: 0.86–1.00; Ptrend = 0.12) when comparing the highest with the lowest quartiles [80]. Recent systemic review and meta-analysis indicated that high intakes of vegetables and fruits were associated with lower risks of breast cancer [81, 82], while a large-scale study demonstrated that the same may be related with improved overall survival among primary breast cancer patients [83]. However, a large prospective study such as the European Prospective Investigation into Cancer and Nutrition did not find a relationship between fruit and vegetable intake, and breast cancer risk [84].
\nCarotenoids such as alpha-carotene, beta-carotene, lycopene and beta-cryptoxanthin are found in fruits and in dark green leafy vegetables as well as in yellow and orange vegetables [85]. The chemo-prevention and protective potential of carotenoids lies in their antioxidant, retinoic and anti-proliferative activities and obstructing estrogen signaling of 17β-estradiol, with subsequent weakening of the properties of malignancies such as breast cancer that are hormone-dependent [86]. There are a number of studies that have examined the relation of breast cancer risk with dietary and/or supplemental consumption of carotenoids [87, 88, 89]. In a large population-based case–control study consisting of 5,707 women with incident invasive breast cancer (3,516 postmenopausal women and 2,363 premenopausal women), there were inverse associations observed among premenopausal women for high levels of alpha-carotene (OR = 0.82, 95% CI: 0.68–0.98) and beta-carotene (OR = 0.81, 95% CI: 0.68–0.98) but not for postmenopausal women [90] (Table 1). Likewise, in the Women’s Health Initiative Observational Study, high dietary beta-carotene intake (RR = 0.78; 95% CI: 0.66–0.94; Ptrend = 0.021) and elevated alpha-carotene (RR = 0.83; 95% CI: = 0.70–0.99; Ptrend = 0.019) were inversely related to risk of estrogen receptor (ER)-positive and progesterone receptor (PR)-positive breast cancer. However, supplemental or total beta-carotene were not related to breast cancers demarcated by PR and ER status [23]. In an earlier population-based case–control study conducted in Canada, Nkondjock et al. found decreased risk for beta-carotene for those who never used hormone replacement therapy [89] but increased breast cancer risk associated with significantly high serum levels of alpha-carotene (OR = 2.40; 95% CI: 0.90–6.41) in premenopausal women.
\nThese findings were corroborated by a review study that systematically summarized the associations between beta-carotene and alpha-carotene, and breast cancer risk. In the meta-analysis that comprehensively review the associations between carotenoids and breast cancer, higher intakes of dietary beta-carotene significantly decreased breast cancer risk by 6.0% (RRpooled = 0.94; 95% CI: 0.88–1.00) and dietary alpha-carotene lower the risk by 9.0% when the cohort studies were pooled. Furthermore, significant dose–response associations were seen in both the higher intake of dietary and total beta-carotene with decreased breast cancer risk when considering cohort studies and case–control studies [91] (Table 3). There are other observational studies that have confirmed an inverse relationship of dietary or supplemental alpha-carotene or beta-carotene with risk of breast cancer [27, 87, 92, 93].
\nHowever, there are few studies that have reported null association between the carotenoids and breast cancer risk [84, 88, 94]. Terry et al. found no clear association between alpha-carotene and beta-carotene, and breast cancer risk in a large cohort of women who were registered in the Canadian National Breast Screening Study [88]. In subsequently large prospective study of women enrolled in the European Prospective Investigation Into Cancer and Nutrition there was no association of dietary beta-carotene with breast cancer risk, although beta-carotene supplement demonstrated a protective effect against lobular breast cancer (IRR = 0.72; 95%CI: 0.57–0.91] [84]. This study also found no association between overall breast cancer and any micronutrients, while some effects were shown when stratifying by breast cancer subtypes [84]. Finally, there is another study that have reported null association between the carotenoids and breast cancer risk [95].
\nBlood vitamin intakes are regarded as biomarkers of the consumption of vegetables and fruits [96]. Plasma or serum levels of antioxidants such as vitamin E are thought to be related to breast cancer risk but results from prospective and case control studies remain inconclusive [97]. In a nested case–control study comprising 1,502 incident breast cancer cases and 1,502 controls within the European Prospective Investigation into Cancer and Nutrition cohort, plasma vitamin E level was not statistically associated with ER negative or ER positive breast cancer [98]. Epplein et al. earlier published a nested case–control study, a sub-cohort of the Multiethnic Cohort Study which demonstrated that multiethnic women with breast cancer were more likely to have lower levels of vitamin E than matched controls [99]. Notably, a meta-analysis of 40 studies by Hu et al. summarize the associations between plasma levels of vitamins A, C and E, and breast cancer risk and observed significant relationship between plasma vitamin E levels and breast cancer incidence (ORpooled = 0.42, 95% CI: 0.25–0.72, p = 0.001). The authors suggested that severe vitamin E could increase breast cancer risk [100]. Furthermore, even though there was an association between serum vitamin E [biomarker of fruit and vegetable intake, (OR = 0.68, 95% CI: 0.41–1.10)] in the E3N-EPIC Study, it was not statistically significant (Ptrend = 0.26) [101].
\nHowever, there are findings from studies that do not support plasma or serum levels of vitamin E being associated with reduced risk of breast cancer [54, 102]. In a nested case–control comprising of 365 incident breast cancer cases and 726 individually matched control women within the prospective population-based Shanghai Women’s Health Study, there was no association between plasma levels of vitamin E and reduced breast cancer risk, although the authors noted that there may be protective effects among sub-groups of women [54]. Likewise, in an earlier case–control study nested in a prospective cohort from the Breast Cancer Serum Bank in Missouri, United States no evidence of the protective effect of vitamin E was observed for breast cancer, although carotenoids such as lycopene and beta-cryptoxanthin may protect against breast cancer [103]. There are other studies that have reported null findings in the relationship between serum or plasma levels of vitamin E and breast cancer risk [102, 104]. These include: no association between plasma vitamin E levels and breast cancer risk in the Nurses’ Health Study [105] and no significant association of plasma vitamin E levels in a nested case-referent study conducted in Sweden [106].
\nFlavonoids are an assembly of naturally occurring phenolic compounds located in vegetables and fruits and are classified into 6 main sub-classes based on the complexity of their structure. They include flavanones, flavones, flavonols, flavan-3-ols, isoflavanones and anthocyanins [107]. Investigational studies have suggested that flavonoids such as flavonols, flavones and flavanones possess preventative biological activity on breast carcinogenesis and is protective against commencement and development of tumor [108]. Nevertheless, epidemiological data regarding the associations between these flavonoid biomarkers and risk of breast cancer is inadequate and is very much needed to evaluate the definite effects of flavonoids in humans [109].
\nThere is epidemiological evidence determined by prospective cohort study and case-study designs that have suggested an associations between dietary and supplemental flavonoids intake and breast cancer risk [110, 111]. In a recent case–control study that examined the relationship between breast cancer risk and total and subclasses of flavonoids, higher dietary intakes of total flavonoids (OR = 0.66, 95% CI: 0.54–0.82), flavonols (OR = 0.51, 95% CI: 0.41–0.63) were inversely associated with breast cancer risk [110] (Table 1). No significant relationship was observed between the flavins, flavan-3-ol monomers and flavanols, and breast cancer risk [110]. These findings are compatible with those of a large case–control study conducted in Italy, where decreased breast cancer risk was found for flavonols (OR = 0.80, Ptrend 0.06) and flavones (OR = 0.81, Ptrend = 0.02), but not for flavan-3-ols, flavanones, isoflavones and anthocyanidins [111]. Similarly, in a subsequent case–control study of United States women reduced breast cancer risk was related with high dietary uptake of flavones (OR = 0.61, 95% CI: 0.45, 0.83), flavonols (OR = 0.54, 95% CI: 0.40–0.73) and flavan-3-ols in postmenopausal women. The authors suggested that consuming sufficient amount of these flavonoids could be beneficial to these women in the chemoprevention of breast cancer [112] (Table 1). Notably, in a recent hospital-based case–control, higher levels of serum flavonols (OR = 0.52, 95% CI 0.38–0.70) and flavanone (OR = 0.45, 95% CI: 0.34–0.60) were significantly associated with decreased breast cancer risk [113]. The outcomes of these studies corroborated those of other case–control studies [114, 115] which supported the protective influence of high dietary intake of flavonols and flavones against breast cancer particularly among postmenopausal females.
\nThe findings from prospective cohort studies are not so favorable regarding the chemo-preventative actions of flavonoids. In a meta-analysis of epidemiologic studies comprising 6 prospective cohort and 6 case–control studies, higher dietary intake of flavones (RR = 0.83, 95% CI: 0.76–0.91), flavonols (RR = 0.88, 95% CI: 0.80–0.98) decreased breast cancer risk although there were no significant relation of flavanones, flavan-3-ols and anthocyanins particularly in post-menopausal women [116] (Table 3). However, The Nurses’ Health Study II investigated the effect of dietary flavonols on breast cancer risk, and found a non-significant null association with a risk ratio of 0.94 (95% CI: 0.72–1.22, Ptrend = 0.54) that was reported for flavonol-rich foods. Furthermore, dietary intakes of flavonol containing foods such as beans and lentils were inversely associated with breast cancer risk but this was not observed for onions, apples, blueberries tea, green pepper and broccoli [117]. There was also no association and thus no protective effects against breast cancer risk for increased intake of flavanones [118, 119, 120], flavanols [118, 119], flavonols [118, 119, 120], flavones [118], anthocyanidins [118] as well as total flavonoids [118, 119, 120, 121, 122].
\nIsoflavones are a subclass of flavonoids and are found in legumes such as soybeans and soy products. These polyphenolic compounds are derived from plants and the three main isoflavones are daidzin, glycitin and genistin [123]. Globally the consumption of soy and soy products is increasing as the health benefits due to their biological actions including estrogenic and anti-estrogenic properties, inhibition of tumor proliferation, antioxidant, anti-inflammatory and lower risk for cardiovascular disease [124, 125]. Notwithstanding potential mechanisms from experimental studies, epidemiological evidence from case–control and prospective cohort studies regarding association of soy food and isoflavone, and breast cancer risk provide unreliable results [126, 127, 128].
\nIn The Shanghai Breast Cancer Survival Study that assessed bone fracture incidence and its relationship with soy food consumption among breast cancer patients, high soy isoflavone intake was concomitant with decreased risk among both peri- and premenopausal subjects (HR = 0.22, 95% CI: 0.09–0.53) but no association for postmenopausal subjects [129] (Table 1). Similarly, a recent study that examined the relationship between isoflavone intake and hereditary breast cancer risk, reported that high intake of this flavonoid was inversely related with luminal A breast cancer hazard in women who are BRCA2 mutation carriers [130]. Conversely, in a large prospective study comprising women from the Epidemiologique aupres de Femmes de la Mutuelle Generale de l’Education Nationale (E3N) cohort, there was no relation between past consumption of soy isoflavones supplement and breast cancer risk (HR = 1.36, 95% CI: 0.95–1.93) particularly among premenopausal patients [131]. Furthermore, in this study, there were contrasting associations of soy supplements with estrogen receptor-positive (HR = 0.78, 95%CI: 0.60–0.99) and estrogen receptor-negative (HR = 2.01, 95%CI: 1.41–2.86) breast cancer risk [131]. In another contemporary study, null association was observed between breast cancer risk and soy products containing isoflavones in a large cohort study of North American women although greater dairy milk intakes were associated with increased breast cancer risk, after adjusted for consumption [132]. The authors suggested that caution should be exercised when viewing existing guidelines for dairy milk intake [132].
\nThere are meta-analyses that have indicated that higher levels of soy products and isoflavones with lower incident breast cancer risk [133, 134]. In a meta-analysis of 35 studies soy isoflavone intake has a protective effect in that it is inversely associated with breast cancer for both pre- (OR = 0.59, 95%CI: 0.48–0.69 and post-menopausal women (OR = 0.59, 95%CI: 0.44–0.74) particularly in Asian women while no evidence of a relationship in Western women [135] (Table 3). Nonetheless, in a previous meta-analysis of prospective cohort studies, there was no significant association between high (versus low) intake of isoflavones (RR = 0.99, 95% CI: 0.91–1.09) and moderate (versus low) intake of isoflavones (RR = 0.99, 95% CI = 0.92–1.05) and breast cancer risk, indicating that women with high dietary intake of soy isoflavones may experience decreased breast cancer incidence [136]. Support for the null finding was observed in a large Multiethnic Cohort study of women with a wide range of soya intake level and who were followed for 13 years, where no statistically association was detected between overall breast cancer risk and high dietary isoflavone intake (HR = 0.96, 95% CI: 0.85–1.08). The authors posited that higher consumption may be protective for Japanese American, Latina and African American women [137]. Notably, a recent publication of the China Kadoorie Biobank (CKB) study which involved a dose–response meta-analysis of dietary data of soy intake over a follow-up period of 10 years, the relative risk for high soy isoflavones consumption was 1.00 (95% CI: 0.81–1.22) [138]. A 3% decreased breast cancer risk for each 10 mg/day increment of soy isoflavones was observed. The results suggests that soy isoflavone was not related with breast cancer risk though increased intake may be beneficial in preventing breast cancer [138].
\nThere are not many case–control studies that investigated the relation between soy isoflavone intake and breast cancer risk. In a case–control study conducted in Japan, increasing intake of isoflavone significantly reduced breast cancer risk in premenopausal women (OR = 0.44; 95% CI: 0.22–0.89), while no significant association was observed among postmenopausal women [139]. This shows the need to conduct more case–control studies in order to afford a clearer picture on the relationship between soy products and breast cancer incidence.
\nThere are studies that have examined the association between soy products and isoflavones intake and breast cancer survival, however the results are not definitive [140, 141, 142]. There are prospective cohort and meta-analyses studies that have reported significant inversely association between soy protein and soy isoflavones and breast cancer survival outcomes. In looking at prospective studies, The Shanghai Breast Cancer Survival Study comprised of 5,033 surgically treated breast cancer patients that were followed for 3.9 years. High soy protein intake was inversely associated with breast cancer recurrence (HR = 0.68, 95%CI: 0.64–0.87) and all-cause mortality (HR = 0.71, 95%CI: 0.54–0.92) among women with either estrogen receptor-positive or -negative breast cancer [143] (Table 2). In an earlier prospective study of 256 Chinese women, elevated soy isoflavones intake was associated with reduced risk of breast cancer mortality (OR = 0.25, 95% CI: 0.09–0.54) and high soy protein was also concomitant with significant decreased breast cancer risk (OR = 0.38, 95% CI: 0.17–0.86) [144] (Table 2). In another study published in the same year involving 339 Korean women, dietary soy isoflavones was inversely related with breast cancer recurrence in HER2-positive breast cancer patients (HR = 0.23, 95%CI: 0.06–0.89) while no effect was observed with total soy intake [145].
\nThe findings from systematic and meta-analysis of prospective cohort and case–control studies are also inconsistent. In a meta-analysis of protective studies, soy isoflavones intake was inversely linked with risk of breast cancer incidence (RR = 0.89, 95% CI: 0.79–0.99) and also inversely concomitant with risk of breast cancer recurrence (RR = 0.84, 95% CI: 0.70–0.99) [146] (Table 3). Likewise, Nachvak et al. conducted a systematic review and dose–response meta-analysis of 23 prospective cohort studies and reported that a 9% reduced risk of breast cancer-specific mortality for each 10 mg/day increase in soy isoflavones intake and a 12% decrease in the same survival outcome for each 5-g/day elevation of soy protein intake [147]. On the other hand, Qiu and Jiang conducted a systematic review and meta-analysis of 12 studies that explored the relationship between soy and isoflavones intake and breast cancer survival and recurrence. Pre- and post-diagnosis of soy and isoflavones intake were associated with minor reduction in risk of breast cancer recurrence (HR = 0.84 95% CI: 0.71–0.98) and breast cancer specific survival (HR = 0.89 95% CI: 0.74–1.07). Stratified analyses revealed no significant relationship between post-diagnosis soy and isoflavones consumption with overall survival (HR = 0.80, 95% CI: 0.62–1.04), and breast cancer specific survival (HR = 0.83, 95%CI: 0.64–1.07) [141].
\nThe consumption of fruits and vegetables particularly those containing lycopene may offer protection against different types of cancers including breast cancer. There are a number of prospective and case–control studies that examined the relationship between dietary lycopene and breast cancer risk. In a case–control study conducted among Chinese women comprising of 122 primary breast cancer cases and 632 age-matched healthy females, high intake of dietary lycopene was statistically strongly associated with lower breast cancer risk (adjusted OR = 0.26, 95% CI: 0.14–0.46) [93] (Table 1). In the Women’s Health Initiative Observational Study comprising 84 805 women with reported 2,879 incident breast cancer cases during a follow-up period of 7.6 years, high intake of dietary lycopene non-significantly reduced breast cancer risk by 15% (RR = 0.85; 95% CI: 0.73–1.00; Ptrend = 0.064) in ER+ and PR+ breast cancer among post-menopausal women [23]. Also, a Swiss case–control study comprising 289 incident breast cancer cases and 442 controls reported a significant inverse association for lycopene with breast cancer risk (OR = 0.64) [148].
\nHowever, there are both prospective and case–control studies that have found null association between dietary lycopene and breast cancer risk. In a case–control study of Chinese women involving of 561 cases and 561 age-matched control high intake of lycopene was not associated with breast cancer risk (0.89, 95% CI: 0·61–1·30) [118]. Likewise, in another case–control study of non-Hispanic White and Hispanic women there was no association and therefore no protective effect of dietary lycopene on breast cancer risk [60]. Furthermore, there are other studies of dietary lycopene intake including prospective cohort [57, 88, 105, 146], case–control [149] and meta-analysis [91] that have found no association of lycopene with breast cancer risk.
\nEpidemiologic studies evaluating whether circulating lycopene is associated with breast cancer risk have yielded equivocal answers. A nested case–control study conducted comprising 295 breast cancer cases and 295 age- and race-matched controls demonstrated significantly strong inverse association of high levels of lycopene with the risk of developing breast cancer [97]. In another case–control study among women in the United States (46 breast cancer cases and 63 controls), there was a strong inverse association of lycopene (OR = 0.32, 95% CI: 0.11 -, 0.94) in breast adipose tissue and risk of breast cancer [150] (Table 1). Likewise, a pilot case–control study of Caucasian and African American women found a weak inverse relation between plasma lycopene concentration and risk of breast cancer (Simon et al., 2000). The findings of these study were in agreement with that of a comprehensive pooled analysis of 8 prospective cohort studies conducted by Eliassen and colleagues. They found serum or plasma levels of lycopene significantly lower the risk of breast cancer patients by 22% (RR = 0.78, 95% CI: 0.62–0.99, Ptrend = 0.02) [151] (Table 3).
\nOthers studies with findings in consonant with an inverse association between serum or plasma levels of lycopene and breast cancer risk include two case–control studies that showed deceased risk among females with elevated mammographic density [152] and blood donors [103] and a nested case–case control in the Nurses’ Health Study [153]. Likewise, in a nested case–control study, stepwise increase in plasma lycopene levels were not associated (RR = 0.95, 1.15, 0.93, 1.00 (reference, P trend = 0.86) with decreased breast cancer risk in older and middle-aged females [154].
\nThere are a few epidemiologic studies that have investigate the protective effect of dietary lutein and zeaxanthin on breast cancer incidence [90, 119, 155]. A case–control study of Chinese women found that lutein/zeaxanthin reduced breast cancer risk by 51% (OR = 0·49, 95% CI: 0·34–0·71) particularly among pre-menopausal women and those exposed to second-hand smoke [119]. In an earlier large population-based case–control study of United States residents, an inverse association was shown for higher consumption of lutein/zeaxanthin (OR = 0.83, 95% CI 0.68–0.99, Ptrend = 0.02) and breast cancer risk among postmenopausal women [90]. Likewise, Bae conducted a pooled analysis of eighteen prospective cohort studies and reported that lutein/zeaxanthin demonstrated protective effect on ER- and PR+ as well as ER-/PR- breast cancer [155].
\nHowever, a case–control study of Chinese women demonstrated that high dietary lutein/zeaxanthin were not inversely associated with breast cancer risk [93]. Similarly, in a large cohort study of Canadian women Terry et al. reported no clear association between dietary intake of lutein/zeaxanthin and risk of breast cancer [88]. In a later meta-analysis involving 33 studies, high dietary intake of lutein/+zeaxanthin offered no protective effect and thus no significant association with breast cancer risk [91].
\nIn addition to epidemiological studies that have discovered the anti-cancer potential of dietary lutein/zeaxanthin, there are a few research that investigated the protective role of this circulating antioxidant. Serum or plasma levels of lutein/zeaxanthin are more suitable biological indicators of the amount of these flavonol available for chemo-preventative action [156]. In a case–control study conducted among Chinese women, there was a significantly strong inverse association of high serum levels of lutein/zeaxanthin with breast cancer risk (OR = 0·26, 95% CI: 0·17–0·38) [157]. Likewise, a nested case–control study comprising 604 incident breast cancer cases and 626 controls in the Nurses’ Health Study found that circulating lycopene, alpha-carotene and beta-cryptoxanthin were concomitant with a significant 40% - 50% decrease in the risk of breast cancer (Ptrend < 0.05) [152]. These findings were corroborated by a comprehensive analysis of 8 cohort studies where lutein/zeaxanthin was significantly inversely associated with breast cancer risk (RR = 0.84, 95% CI: 0.70–1.01, Ptrend = 0.05) [151]. Interestingly, in a nested case–control study (270 breast cancer cases, 270 matched controls) the risk of breast cancer increased due to low blood levels (OR = 2.08, 95% CI: 1.11–3.90) [158].
\nHowever, In a nested case–control study (1502 breast cancer cases and 1502 individually matched controls) conducted within the European Prospective Investigation into Cancer and Nutrition cohort, there was no statistical association of plasma levels of lutein with of ER- breast tumors [98]. Supporting evidence was also observed in a case–control cohort (201 breast cancer cases and 290 referents) where plasma concentrations of lutein was significantly inversely related with breast cancer risk in premenopausal women [106].
\nThe number of epidemiological research involving quercetin and potential relationship with breast cancer risk is lacking. In a linkage of multi-centered case–control studies conducted in Italy (comprising 10,000 incident breast cancer cases and 16,000 controls) high intake of flavonols including quercetin was inversely associated with breast cancer risk (OR = 0.80) [158]. Similarly, in an earlier large-case control study also conducted in Italy (2,569 incident breast cancer cases and 2,588 controls), increasing consumption of flavonols decreased breast cancer risk by 20% (OR = 0.80; Ptrend, 0.06) [111]. The findings of another large case–control study comprising Greek women was consistent with these two previous results where a strong significant inverse relationship of daily flavonols in fruit comprising quercetin with breast cancer risk [114]. Higher intake of quercetin reduced breast cancer risk by 38% (RR = 0.62, 95%CI: 0.37–1.03, P = 0.25) and the relation was stronger when modification was made in lieu of other dietary sources with a lower risk of 46% (RR = 0.54, 95%CI: 0.30–0.95, P = 0.14) [120]. Lastly, in a meta-analyses of 6 case–controls and 6 prospective cohort studies, breast cancer risk due to high intake (compared with low consumption) of flavonols such as quercetin declined by 12% in females (RR = 0.88, 95% CI: 0.80–0.98). It was also observed that further analyses of 3 case–control studies, high flavonol intake (compared with low consumption) was associated with decreased breast cancer risk in post-menopausal women [116].
\nGreen tea is a product of dry tea leaves of the plant Camellia sinensis, and numerous pre-clinical and epidemiologic studies have been conducted examining the possible protective effect of green tea from various types of human cancers including breast carcinoma [159]. Epidemiologic studies have described a protecting effect of green tea consumption against the initiation and progression of breast cancer, although the results has not being conclusive. A case–control study (1009 incident breast cancer cases and 1009 age-matched controls) of regular green tea (dried green tea leaves per annum) consumption in a dose-dependent manner significantly reduced breast cancer risk [(OR = 0.87, 95% CI: 0.73–1.04) for 1–249 g; (OR = 0.68, 95% CI: 0.54–0.86) for 250–499 g and (OR = 0.59, 95 CI: 0.45–0.77) for 500–749 g, Ptrend < 0.001) [160]. Likewise, in a population-based, case–control study of Asian women with breast cancer (501 breast cancer patients and 594 controls), there was a significant trend of reducing risk with cumulative amount of green tea consumption ([OR = 0.71, 95% CI: 0.51–0.99) and (OR = 0.53, 95% CI: 0.35–0.78) for 0–85.7 ml and > 85.7 ml of green tea per day respectively] [161]. These findings were corroborated by a population-based case–control study of Chinese women in which regular green tea mildly decreased breast cancer risk by 18% (OR = 0.88; 95% CI: 0.79–0.98). It was observed that a dose-dependent association existed with the quantity of green tea intake per month and catechol-O-methyltransferase rs4680 genotypes did not modify the relationship [162].
\nTwo other nested case–control studies are consistent with the protective effect of green tea consumption. Yuan et al. piloted a nested case–control study (297 incident breast cancer cases and 665 controls) inside the Singapore Chinese Health Study and found that frequent green tea consumption significantly decreases breast cancer risk in women with high angiotensin-converting enzyme activity (OR = 0.33, 95%CI: 0.13–0.82, Ptrend = 0.039) [163]. In an earlier nested case–control study (380 incident breast cancer cases and 662 controls) also within the Singapore Chinese Health Study, women with low folate intake and daily or weekly green tea consumption had a 55% reduced breast cancer risk (OR = 0.45, 95% CI: 0.26–0.79, Pinteraction = 0.02). Green tea consumption was not associated with breast cancer risk at high folate intake and the authors suggested that inhibition of the folate intake may be a possible mechanism which account for the protective effect of green tea against breast carcinoma [164].
\nThere are two meta-analyses that support the reduction of breast cancer incidence and recurrence due to green tea consumption. A meta-analysis of studies by Ogunleye et al. of breast cancer recurrence and risk comprising 5,617 cases showed that increased green tea intake (greater than 3 cups/day) was inversely related with breast cancer recurrence (RRpooled = 0.73, 95%CI: 0.56–0.96 [165] (Ogunleye et al., 2010). An analysis of only case–control studies showed that the inverse relationship was preserved (RRpooled = 0.81, 95%CI: 0.75–0.88) while there was no protective effect and therefore null association of breast cancer risk among prospective cohort studies [165]. There was additional supportive evidence in a more recent meta-analysis of 13 studies (5 case–control and 8 cohort studies comprising of 63,810 women) where a statistically significant inverse association existed between green tea consumption and breast cancer incidence with a 15% risk reduction (ORpooled = 0.85, 95% CI: 0.80–0.92, p = 0.0001) [166]. Analysis of only case–control studies also showed a significant inverse relationship with a 19% decrease in the risk of breast cancer (ORpooled = 0.81, 95%CI: 0.74–0.88, p = 0.000) [166].
\nThe results of prospective cohort studies demonstrating a protective effects against breast cancer were less conclusive with some of the studies reporting null association. In a prospective cohort study of the Hospital-based Epidemiologic Research Program in Japan, there was reduced breast cancer recurrence among subjects who consumed 3 or more cups of green tea (HR = 0.69, 95%CI: 0.47–1.00), particularly in stage I disease (HR = 0.43, 95%CI: 0.22–0.84) [167]. In the Shanghai Women’s Health Study, a large population based study comprising 74,942 Chinese females, subjects who began drinking green tea less than or at 25 years of age were less likely to develop breast cancer (HR = 0.69, 95% CI: 0.41–1.17) [168]. However, in a later population-based prospective cohort study also conducted in Japan, there was no association of breast cancer risk and green tea consumption (> 5 or more cups/day; HR = 1.12, 95%CI: 0.81–1.56; Ptrend = 0.60) [169]. Green tea intake was not associated with a reduced breast cancer risk in another prospective study conducted in Japan [170] and in 2 prospective studies piloted among 35,004 Japanese women (RR = 0.84, 95%CI: 0.57–1.24; > 5 cups/day) [171].
\nEpigallocatechin-3-gallate is a natural antioxidant and it has been reported to be more efficient at arresting reactive oxygen species and other radical than vitamin C and E [172]. Experimental studies have demonstrated that epigallocatechin-3-gallate, the biologically active and most abundant tea catechins displays anticancer and chemotherapeutic effects against breast cancer [173]. Epidemiologic studies relating to epigallocatechin-3-gallate are lacking. In a nested case–control study (144 incident breast cancer cases and 288 age-matched controls) in the Japan Public Health Center-based Prospective Study, elevated plasma levels of epigallocatechin-3-gallate along with epicatechin-3-gallate, epicatechin and epigallocatechin were not associated with reduced breast cancer risk [epigallocatechin-3-gallate (OR = 1.21, 95%CI: 0.52–2.80; Ptrend = 0.53)] [169]. In another study published three years ago, green tea extract capsules comprising 843 mg epigallocatechin-3-gallate administered for 1 year decreased mammographic density in healthy postmenopausal women [174]. Interesting, epigallocatechin-3-gallate (400 mg capsules, 3 times/day for 2–8 weeks) orally administered to breast cancer subjects undergoing radiotherapy potentiate the effectiveness of the treatment as evident by decreased metalloproteinase-9 and metalloproteinase-2 activities and elevated serum concentration of vascular endothelial growth factor [175].
\nThe few reports of epidemiologic evidence of epigallocatechin-3-gallate and inconclusive findings in prospective studies suggests that further exploration of its probable chemo-preventative.
\nThe epidemiological evidence shown by a number of case–control, prospective cohort studies as well as meta-analysis and systematic reviews presented does support the view that nutritional micronutrients with antioxidant properties in dietary or supplemental form may be beneficial in protecting women against breast cancer. However, there are studies that have demonstrated null association between the dietary and supplemental micronutrients, and the risk or survival outcomes of breast cancer. Thus overall the findings are inconsistent and epidemiological data on some of the antioxidants as it relates to breast cancer outcomes such as recurrence, and breast cancer-specific and all-cause mortality is inadequate.
\nNotably, there is substantial evidence which is well documented in the literature of the protective action and modification of many signaling pathways and molecular events by these antioxidants inducing apoptosis, inhibition of breast cancer cell proliferation and invasion, and preventing angiogenesis and metastasis. However, the findings of epidemiological results are somewhat disappointing and are not concurrent with experimental results for most of these natural antioxidants. There are limiting factors which negatively impact epidemiological association studies such as genetic, confounding lifestyle, samples sizes, possible selection bias in case–control studies, the length of intervention, possible recall bias in retrospective studies, not accurately measuring dietary intake in prospective studies, interaction among different micronutrients which may nullify individual effect among others.
\nNevertheless, despite the inconsistencies, the findings of the chemo-preventative effects of vitamins, flavonoids and green tea presented in this review are encouraging. There need to be more large-scale and randomized controlled studies to investigate the association of these antioxidants and outcomes such as breast cancer recurrence, and breast cancer-specific mortality. More studies investigating the dietary intake of these antioxidants with sub-types of breast cancer, namely ER and PR status among both premenopausal and postmenopausal women is warranted. The elucidation of the mechanism of action by which these antioxidants decrease breast cancer risk may be helpful in recognizing sub-groups who could benefit from the consumption of these antioxidants with better dietary endorsements for the prevention of breast cancer.
\nFurthermore, the finding that the inhibition of folate intake may be a possible mechanism which account for the protective effect of green tea against breast cancer is noted. Large prospective randomized control trials are warranted as they could provide definitive information on the beneficial or harmful effects of green tea intake on breast cancer development.
\nIntechOpen celebrates Open Access academic research of women scientists: Call Opens on February 11, 2018 and closes on March 8th, 2018.
",metaTitle:'Call for Applications: "IntechOpen Women in Science 2018" Book Collection',metaDescription:"IntechOpen celebrates Open Access academic research of women scientists: Call Opens on February 11, 2018 and closes on March 8th, 2018.",metaKeywords:null,canonicalURL:"/page/women-in-science-book-collection-2018/",contentRaw:'[{"type":"htmlEditorComponent","content":"On February 9th, 2018, which marks the official celebration of UNESCO’s International Day of Women and Girls in Science, we have announced we are seeking contributors for the upcoming “IntechOpen Women in Science 2018” Book Collection. The program aims to support women scientists worldwide whose academic needs include quality assurance, peer-review, fast publishing, collaboration among complementary authors, immediate exposure, and post-publishing citations reporting.
\\n\\nAPPLYING FOR THE “INTECHOPEN WOMEN IN SCIENCE 2018” OPEN ACCESS BOOK COLLECTION
\\n\\nWomen scientists can apply for one book topic, either as an editor or with co-editors, for a publication of an OA book in any of the scientific categories that will be evaluated by The Women in Science Book Collection Committee, led by IntechOpen’s Editorial Board. Submitted proposals will be sent to designated members of the IntechOpen Editorial Advisory Board who will evaluate proposals based on the following parameters: the proposal’s originality, the topic’s relation to recent trends in the corresponding scientific field, and significance to the scientific community.
\\n\\nThe submissions are now closed. All applicants will be notified on the results in due time. Thank you for participating!
\\n"}]'},components:[{type:"htmlEditorComponent",content:"On February 9th, 2018, which marks the official celebration of UNESCO’s International Day of Women and Girls in Science, we have announced we are seeking contributors for the upcoming “IntechOpen Women in Science 2018” Book Collection. The program aims to support women scientists worldwide whose academic needs include quality assurance, peer-review, fast publishing, collaboration among complementary authors, immediate exposure, and post-publishing citations reporting.
\n\nAPPLYING FOR THE “INTECHOPEN WOMEN IN SCIENCE 2018” OPEN ACCESS BOOK COLLECTION
\n\nWomen scientists can apply for one book topic, either as an editor or with co-editors, for a publication of an OA book in any of the scientific categories that will be evaluated by The Women in Science Book Collection Committee, led by IntechOpen’s Editorial Board. Submitted proposals will be sent to designated members of the IntechOpen Editorial Advisory Board who will evaluate proposals based on the following parameters: the proposal’s originality, the topic’s relation to recent trends in the corresponding scientific field, and significance to the scientific community.
\n\nThe submissions are now closed. All applicants will be notified on the results in due time. Thank you for participating!
\n"}]},successStories:{items:[]},authorsAndEditors:{filterParams:{sort:"featured,name"},profiles:[{id:"6700",title:"Dr.",name:"Abbass A.",middleName:null,surname:"Hashim",slug:"abbass-a.-hashim",fullName:"Abbass A. Hashim",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/6700/images/1864_n.jpg",biography:"Currently I am carrying out research in several areas of interest, mainly covering work on chemical and bio-sensors, semiconductor thin film device fabrication and characterisation.\nAt the moment I have very strong interest in radiation environmental pollution and bacteriology treatment. The teams of researchers are working very hard to bring novel results in this field. I am also a member of the team in charge for the supervision of Ph.D. students in the fields of development of silicon based planar waveguide sensor devices, study of inelastic electron tunnelling in planar tunnelling nanostructures for sensing applications and development of organotellurium(IV) compounds for semiconductor applications. I am a specialist in data analysis techniques and nanosurface structure. I have served as the editor for many books, been a member of the editorial board in science journals, have published many papers and hold many patents.",institutionString:null,institution:{name:"Sheffield Hallam University",country:{name:"United Kingdom"}}},{id:"54525",title:"Prof.",name:"Abdul Latif",middleName:null,surname:"Ahmad",slug:"abdul-latif-ahmad",fullName:"Abdul Latif Ahmad",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"20567",title:"Prof.",name:"Ado",middleName:null,surname:"Jorio",slug:"ado-jorio",fullName:"Ado Jorio",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Universidade Federal de Minas Gerais",country:{name:"Brazil"}}},{id:"47940",title:"Dr.",name:"Alberto",middleName:null,surname:"Mantovani",slug:"alberto-mantovani",fullName:"Alberto Mantovani",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"12392",title:"Mr.",name:"Alex",middleName:null,surname:"Lazinica",slug:"alex-lazinica",fullName:"Alex Lazinica",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/12392/images/7282_n.png",biography:"Alex Lazinica is the founder and CEO of IntechOpen. After obtaining a Master's degree in Mechanical Engineering, he continued his PhD studies in Robotics at the Vienna University of Technology. Here he worked as a robotic researcher with the university's Intelligent Manufacturing Systems Group as well as a guest researcher at various European universities, including the Swiss Federal Institute of Technology Lausanne (EPFL). During this time he published more than 20 scientific papers, gave presentations, served as a reviewer for major robotic journals and conferences and most importantly he co-founded and built the International Journal of Advanced Robotic Systems- world's first Open Access journal in the field of robotics. Starting this journal was a pivotal point in his career, since it was a pathway to founding IntechOpen - Open Access publisher focused on addressing academic researchers needs. Alex is a personification of IntechOpen key values being trusted, open and entrepreneurial. Today his focus is on defining the growth and development strategy for the company.",institutionString:null,institution:{name:"TU Wien",country:{name:"Austria"}}},{id:"19816",title:"Prof.",name:"Alexander",middleName:null,surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/19816/images/1607_n.jpg",biography:"Alexander I. Kokorin: born: 1947, Moscow; DSc., PhD; Principal Research Fellow (Research Professor) of Department of Kinetics and Catalysis, N. Semenov Institute of Chemical Physics, Russian Academy of Sciences, Moscow.\r\nArea of research interests: physical chemistry of complex-organized molecular and nanosized systems, including polymer-metal complexes; the surface of doped oxide semiconductors. He is an expert in structural, absorptive, catalytic and photocatalytic properties, in structural organization and dynamic features of ionic liquids, in magnetic interactions between paramagnetic centers. The author or co-author of 3 books, over 200 articles and reviews in scientific journals and books. He is an actual member of the International EPR/ESR Society, European Society on Quantum Solar Energy Conversion, Moscow House of Scientists, of the Board of Moscow Physical Society.",institutionString:null,institution:{name:"Semenov Institute of Chemical Physics",country:{name:"Russia"}}},{id:"62389",title:"PhD.",name:"Ali Demir",middleName:null,surname:"Sezer",slug:"ali-demir-sezer",fullName:"Ali Demir Sezer",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/62389/images/3413_n.jpg",biography:"Dr. Ali Demir Sezer has a Ph.D. from Pharmaceutical Biotechnology at the Faculty of Pharmacy, University of Marmara (Turkey). He is the member of many Pharmaceutical Associations and acts as a reviewer of scientific journals and European projects under different research areas such as: drug delivery systems, nanotechnology and pharmaceutical biotechnology. Dr. Sezer is the author of many scientific publications in peer-reviewed journals and poster communications. Focus of his research activity is drug delivery, physico-chemical characterization and biological evaluation of biopolymers micro and nanoparticles as modified drug delivery system, and colloidal drug carriers (liposomes, nanoparticles etc.).",institutionString:null,institution:{name:"Marmara University",country:{name:"Turkey"}}},{id:"61051",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:null},{id:"100762",title:"Prof.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"St David's Medical Center",country:{name:"United States of America"}}},{id:"107416",title:"Dr.",name:"Andrea",middleName:null,surname:"Natale",slug:"andrea-natale",fullName:"Andrea Natale",position:null,profilePictureURL:"//cdnintech.com/web/frontend/www/assets/author.svg",biography:null,institutionString:null,institution:{name:"Texas Cardiac Arrhythmia",country:{name:"United States of America"}}},{id:"64434",title:"Dr.",name:"Angkoon",middleName:null,surname:"Phinyomark",slug:"angkoon-phinyomark",fullName:"Angkoon Phinyomark",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/64434/images/2619_n.jpg",biography:"My name is Angkoon Phinyomark. I received a B.Eng. degree in Computer Engineering with First Class Honors in 2008 from Prince of Songkla University, Songkhla, Thailand, where I received a Ph.D. degree in Electrical Engineering. My research interests are primarily in the area of biomedical signal processing and classification notably EMG (electromyography signal), EOG (electrooculography signal), and EEG (electroencephalography signal), image analysis notably breast cancer analysis and optical coherence tomography, and rehabilitation engineering. I became a student member of IEEE in 2008. During October 2011-March 2012, I had worked at School of Computer Science and Electronic Engineering, University of Essex, Colchester, Essex, United Kingdom. In addition, during a B.Eng. I had been a visiting research student at Faculty of Computer Science, University of Murcia, Murcia, Spain for three months.\n\nI have published over 40 papers during 5 years in refereed journals, books, and conference proceedings in the areas of electro-physiological signals processing and classification, notably EMG and EOG signals, fractal analysis, wavelet analysis, texture analysis, feature extraction and machine learning algorithms, and assistive and rehabilitative devices. I have several computer programming language certificates, i.e. Sun Certified Programmer for the Java 2 Platform 1.4 (SCJP), Microsoft Certified Professional Developer, Web Developer (MCPD), Microsoft Certified Technology Specialist, .NET Framework 2.0 Web (MCTS). I am a Reviewer for several refereed journals and international conferences, such as IEEE Transactions on Biomedical Engineering, IEEE Transactions on Industrial Electronics, Optic Letters, Measurement Science Review, and also a member of the International Advisory Committee for 2012 IEEE Business Engineering and Industrial Applications and 2012 IEEE Symposium on Business, Engineering and Industrial Applications.",institutionString:null,institution:{name:"Joseph Fourier University",country:{name:"France"}}},{id:"55578",title:"Dr.",name:"Antonio",middleName:null,surname:"Jurado-Navas",slug:"antonio-jurado-navas",fullName:"Antonio Jurado-Navas",position:null,profilePictureURL:"https://mts.intechopen.com/storage/users/55578/images/4574_n.png",biography:"Antonio Jurado-Navas received the M.S. degree (2002) and the Ph.D. degree (2009) in Telecommunication Engineering, both from the University of Málaga (Spain). He first worked as a consultant at Vodafone-Spain. From 2004 to 2011, he was a Research Assistant with the Communications Engineering Department at the University of Málaga. In 2011, he became an Assistant Professor in the same department. From 2012 to 2015, he was with Ericsson Spain, where he was working on geo-location\ntools for third generation mobile networks. Since 2015, he is a Marie-Curie fellow at the Denmark Technical University. His current research interests include the areas of mobile communication systems and channel modeling in addition to atmospheric optical communications, adaptive optics and statistics",institutionString:null,institution:{name:"University of Malaga",country:{name:"Spain"}}}],filtersByRegion:[{group:"region",caption:"North America",value:1,count:5766},{group:"region",caption:"Middle and South America",value:2,count:5227},{group:"region",caption:"Africa",value:3,count:1717},{group:"region",caption:"Asia",value:4,count:10366},{group:"region",caption:"Australia and Oceania",value:5,count:897},{group:"region",caption:"Europe",value:6,count:15789}],offset:12,limit:12,total:118187},chapterEmbeded:{data:{}},editorApplication:{success:null,errors:{}},ofsBooks:{filterParams:{hasNoEditors:"1",sort:"dateEndThirdStepPublish"},books:[{type:"book",id:"10231",title:"Proton Therapy",subtitle:null,isOpenForSubmission:!0,hash:"f4a9009287953c8d1d89f0fa9b7597b0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10231.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10652",title:"Visual Object Tracking",subtitle:null,isOpenForSubmission:!0,hash:"96f3ee634a7ba49fa195e50475412af4",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10652.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10653",title:"Optimization Algorithms",subtitle:null,isOpenForSubmission:!0,hash:"753812dbb9a6f6b57645431063114f6c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10653.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10655",title:"Motion Planning",subtitle:null,isOpenForSubmission:!0,hash:"809b5e290cf2dade9e7e0a5ae0ef3df0",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10655.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10657",title:"Service Robots",subtitle:null,isOpenForSubmission:!0,hash:"5f81b9eea6eb3f9af984031b7af35588",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10657.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10662",title:"Pedagogy",subtitle:null,isOpenForSubmission:!0,hash:"c858e1c6fb878d3b895acbacec624576",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10662.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10673",title:"The Psychology of Trust",subtitle:null,isOpenForSubmission:!0,hash:"1f6cac41fd145f718ac0866264499cc8",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10673.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10675",title:"Hydrostatics",subtitle:null,isOpenForSubmission:!0,hash:"c86c2fa9f835d4ad5e7efd8b01921866",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10675.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10677",title:"Topology",subtitle:null,isOpenForSubmission:!0,hash:"85eac84b173d785f989522397616124e",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10677.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10678",title:"Biostatistics",subtitle:null,isOpenForSubmission:!0,hash:"f63db439474a574454a66894db8b394c",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10678.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10679",title:"Mass Production",subtitle:null,isOpenForSubmission:!0,hash:"2dae91102099b1a07be1a36a68852829",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10679.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10684",title:"Biorefineries",subtitle:null,isOpenForSubmission:!0,hash:"23962c6b77348bcbf247c673d34562f6",slug:null,bookSignature:"",coverURL:"https://cdn.intechopen.com/books/images_new/10684.jpg",editedByType:null,editors:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],filtersByTopic:[{group:"topic",caption:"Agricultural and Biological Sciences",value:5,count:7},{group:"topic",caption:"Biochemistry, Genetics and Molecular Biology",value:6,count:6},{group:"topic",caption:"Business, Management and Economics",value:7,count:5},{group:"topic",caption:"Chemistry",value:8,count:1},{group:"topic",caption:"Computer and Information Science",value:9,count:5},{group:"topic",caption:"Earth and Planetary Sciences",value:10,count:3},{group:"topic",caption:"Engineering",value:11,count:6},{group:"topic",caption:"Environmental Sciences",value:12,count:4},{group:"topic",caption:"Immunology and Microbiology",value:13,count:2},{group:"topic",caption:"Mathematics",value:15,count:3},{group:"topic",caption:"Medicine",value:16,count:27},{group:"topic",caption:"Neuroscience",value:18,count:1},{group:"topic",caption:"Pharmacology, Toxicology and Pharmaceutical Science",value:19,count:3},{group:"topic",caption:"Physics",value:20,count:2},{group:"topic",caption:"Psychology",value:21,count:3},{group:"topic",caption:"Robotics",value:22,count:4},{group:"topic",caption:"Social Sciences",value:23,count:3},{group:"topic",caption:"Technology",value:24,count:1}],offset:12,limit:12,total:87},popularBooks:{featuredBooks:[{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7841",title:"New Insights Into Metabolic Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"ef5accfac9772b9e2c9eff884f085510",slug:"new-insights-into-metabolic-syndrome",bookSignature:"Akikazu Takada",coverURL:"https://cdn.intechopen.com/books/images_new/7841.jpg",editors:[{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8558",title:"Aerodynamics",subtitle:null,isOpenForSubmission:!1,hash:"db7263fc198dfb539073ba0260a7f1aa",slug:"aerodynamics",bookSignature:"Mofid Gorji-Bandpy and Aly-Mousaad Aly",coverURL:"https://cdn.intechopen.com/books/images_new/8558.jpg",editors:[{id:"35542",title:"Prof.",name:"Mofid",middleName:null,surname:"Gorji-Bandpy",slug:"mofid-gorji-bandpy",fullName:"Mofid Gorji-Bandpy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9668",title:"Chemistry and Biochemistry of Winemaking, Wine Stabilization and Aging",subtitle:null,isOpenForSubmission:!1,hash:"c5484276a314628acf21ec1bdc3a86b9",slug:"chemistry-and-biochemistry-of-winemaking-wine-stabilization-and-aging",bookSignature:"Fernanda Cosme, Fernando M. Nunes and Luís Filipe-Ribeiro",coverURL:"https://cdn.intechopen.com/books/images_new/9668.jpg",editors:[{id:"186819",title:"Prof.",name:"Fernanda",middleName:null,surname:"Cosme",slug:"fernanda-cosme",fullName:"Fernanda Cosme"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7847",title:"Medical Toxicology",subtitle:null,isOpenForSubmission:!1,hash:"db9b65bea093de17a0855a1b27046247",slug:"medical-toxicology",bookSignature:"Pınar Erkekoglu and Tomohisa Ogawa",coverURL:"https://cdn.intechopen.com/books/images_new/7847.jpg",editors:[{id:"109978",title:"Prof.",name:"Pınar",middleName:null,surname:"Erkekoglu",slug:"pinar-erkekoglu",fullName:"Pınar Erkekoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8620",title:"Mining Techniques",subtitle:"Past, Present and Future",isOpenForSubmission:!1,hash:"b65658f81d14e9e57e49377869d3a575",slug:"mining-techniques-past-present-and-future",bookSignature:"Abhay Soni",coverURL:"https://cdn.intechopen.com/books/images_new/8620.jpg",editors:[{id:"271093",title:"Dr.",name:"Abhay",middleName:null,surname:"Soni",slug:"abhay-soni",fullName:"Abhay Soni"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9660",title:"Inland Waters",subtitle:"Dynamics and Ecology",isOpenForSubmission:!1,hash:"975c26819ceb11a926793bc2adc62bd6",slug:"inland-waters-dynamics-and-ecology",bookSignature:"Adam Devlin, Jiayi Pan and Mohammad Manjur Shah",coverURL:"https://cdn.intechopen.com/books/images_new/9660.jpg",editors:[{id:"280757",title:"Dr.",name:"Adam",middleName:"Thomas",surname:"Devlin",slug:"adam-devlin",fullName:"Adam Devlin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9122",title:"Cosmetic Surgery",subtitle:null,isOpenForSubmission:!1,hash:"207026ca4a4125e17038e770d00ee152",slug:"cosmetic-surgery",bookSignature:"Yueh-Bih Tang",coverURL:"https://cdn.intechopen.com/books/images_new/9122.jpg",editors:[{id:"202122",title:"Prof.",name:"Yueh-Bih",middleName:null,surname:"Tang",slug:"yueh-bih-tang",fullName:"Yueh-Bih Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9043",title:"Parenting",subtitle:"Studies by an Ecocultural and Transactional Perspective",isOpenForSubmission:!1,hash:"6d21066c7438e459e4c6fb13217a5c8c",slug:"parenting-studies-by-an-ecocultural-and-transactional-perspective",bookSignature:"Loredana Benedetto and Massimo Ingrassia",coverURL:"https://cdn.intechopen.com/books/images_new/9043.jpg",editors:[{id:"193200",title:"Prof.",name:"Loredana",middleName:null,surname:"Benedetto",slug:"loredana-benedetto",fullName:"Loredana Benedetto"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9731",title:"Oxidoreductase",subtitle:null,isOpenForSubmission:!1,hash:"852e6f862c85fc3adecdbaf822e64e6e",slug:"oxidoreductase",bookSignature:"Mahmoud Ahmed Mansour",coverURL:"https://cdn.intechopen.com/books/images_new/9731.jpg",editors:[{id:"224662",title:"Prof.",name:"Mahmoud Ahmed",middleName:null,surname:"Mansour",slug:"mahmoud-ahmed-mansour",fullName:"Mahmoud Ahmed Mansour"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:12,limit:12,total:5221},hotBookTopics:{hotBooks:[],offset:0,limit:12,total:null},publish:{},publishingProposal:{success:null,errors:{}},books:{featuredBooks:[{type:"book",id:"9385",title:"Renewable Energy",subtitle:"Technologies and Applications",isOpenForSubmission:!1,hash:"a6b446d19166f17f313008e6c056f3d8",slug:"renewable-energy-technologies-and-applications",bookSignature:"Tolga Taner, Archana Tiwari and Taha Selim Ustun",coverURL:"https://cdn.intechopen.com/books/images_new/9385.jpg",editors:[{id:"197240",title:"Associate Prof.",name:"Tolga",middleName:null,surname:"Taner",slug:"tolga-taner",fullName:"Tolga Taner"}],equalEditorOne:{id:"186791",title:"Dr.",name:"Archana",middleName:null,surname:"Tiwari",slug:"archana-tiwari",fullName:"Archana Tiwari",profilePictureURL:"https://mts.intechopen.com/storage/users/186791/images/system/186791.jpg",biography:"Dr. Archana Tiwari is Associate Professor at Amity University, India. Her research interests include renewable sources of energy from microalgae and further utilizing the residual biomass for the generation of value-added products, bioremediation through microalgae and microbial consortium, antioxidative enzymes and stress, and nutraceuticals from microalgae. She has been working on algal biotechnology for the last two decades. She has published her research in many international journals and has authored many books and chapters with renowned publishing houses. She has also delivered talks as an invited speaker at many national and international conferences. Dr. Tiwari is the recipient of several awards including Researcher of the Year and Distinguished Scientist.",institutionString:"Amity University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"3",totalChapterViews:"0",totalEditedBooks:"1",institution:{name:"Amity University",institutionURL:null,country:{name:"India"}}},equalEditorTwo:{id:"197609",title:"Prof.",name:"Taha Selim",middleName:null,surname:"Ustun",slug:"taha-selim-ustun",fullName:"Taha Selim Ustun",profilePictureURL:"https://mts.intechopen.com/storage/users/197609/images/system/197609.jpeg",biography:"Dr. Taha Selim Ustun received a Ph.D. in Electrical Engineering from Victoria University, Melbourne, Australia. He is a researcher with the Fukushima Renewable Energy Institute, AIST (FREA), where he leads the Smart Grid Cybersecurity Laboratory. Prior to that, he was a faculty member with the School of Electrical and Computer Engineering, Carnegie Mellon University, Pittsburgh, PA, USA. His current research interests include power systems protection, communication in power networks, distributed generation, microgrids, electric vehicle integration, and cybersecurity in smart grids. He serves on the editorial boards of IEEE Access, IEEE Transactions on Industrial Informatics, Energies, Electronics, Electricity, World Electric Vehicle and Information journals. Dr. Ustun is a member of the IEEE 2004 and 2800, IEC Renewable Energy Management WG 8, and IEC TC 57 WG17. He has been invited to run specialist courses in Africa, India, and China. He has delivered talks for the Qatar Foundation, the World Energy Council, the Waterloo Global Science Initiative, and the European Union Energy Initiative (EUEI). His research has attracted funding from prestigious programs in Japan, Australia, the European Union, and North America.",institutionString:"Fukushima Renewable Energy Institute, AIST (FREA)",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"National Institute of Advanced Industrial Science and Technology",institutionURL:null,country:{name:"Japan"}}},equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8985",title:"Natural Resources Management and Biological Sciences",subtitle:null,isOpenForSubmission:!1,hash:"5c2e219a6c021a40b5a20c041dea88c4",slug:"natural-resources-management-and-biological-sciences",bookSignature:"Edward R. Rhodes and Humood Naser",coverURL:"https://cdn.intechopen.com/books/images_new/8985.jpg",editors:[{id:"280886",title:"Prof.",name:"Edward R",middleName:null,surname:"Rhodes",slug:"edward-r-rhodes",fullName:"Edward R Rhodes"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9027",title:"Human Blood Group Systems and Haemoglobinopathies",subtitle:null,isOpenForSubmission:!1,hash:"d00d8e40b11cfb2547d1122866531c7e",slug:"human-blood-group-systems-and-haemoglobinopathies",bookSignature:"Osaro Erhabor and Anjana Munshi",coverURL:"https://cdn.intechopen.com/books/images_new/9027.jpg",editors:[{id:"35140",title:null,name:"Osaro",middleName:null,surname:"Erhabor",slug:"osaro-erhabor",fullName:"Osaro Erhabor"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7841",title:"New Insights Into Metabolic Syndrome",subtitle:null,isOpenForSubmission:!1,hash:"ef5accfac9772b9e2c9eff884f085510",slug:"new-insights-into-metabolic-syndrome",bookSignature:"Akikazu Takada",coverURL:"https://cdn.intechopen.com/books/images_new/7841.jpg",editors:[{id:"248459",title:"Dr.",name:"Akikazu",middleName:null,surname:"Takada",slug:"akikazu-takada",fullName:"Akikazu Takada"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8558",title:"Aerodynamics",subtitle:null,isOpenForSubmission:!1,hash:"db7263fc198dfb539073ba0260a7f1aa",slug:"aerodynamics",bookSignature:"Mofid Gorji-Bandpy and Aly-Mousaad Aly",coverURL:"https://cdn.intechopen.com/books/images_new/8558.jpg",editors:[{id:"35542",title:"Prof.",name:"Mofid",middleName:null,surname:"Gorji-Bandpy",slug:"mofid-gorji-bandpy",fullName:"Mofid Gorji-Bandpy"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9668",title:"Chemistry and Biochemistry of Winemaking, Wine Stabilization and Aging",subtitle:null,isOpenForSubmission:!1,hash:"c5484276a314628acf21ec1bdc3a86b9",slug:"chemistry-and-biochemistry-of-winemaking-wine-stabilization-and-aging",bookSignature:"Fernanda Cosme, Fernando M. Nunes and Luís Filipe-Ribeiro",coverURL:"https://cdn.intechopen.com/books/images_new/9668.jpg",editors:[{id:"186819",title:"Prof.",name:"Fernanda",middleName:null,surname:"Cosme",slug:"fernanda-cosme",fullName:"Fernanda Cosme"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"7847",title:"Medical Toxicology",subtitle:null,isOpenForSubmission:!1,hash:"db9b65bea093de17a0855a1b27046247",slug:"medical-toxicology",bookSignature:"Pınar Erkekoglu and Tomohisa Ogawa",coverURL:"https://cdn.intechopen.com/books/images_new/7847.jpg",editors:[{id:"109978",title:"Prof.",name:"Pınar",middleName:null,surname:"Erkekoglu",slug:"pinar-erkekoglu",fullName:"Pınar Erkekoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"8620",title:"Mining Techniques",subtitle:"Past, Present and Future",isOpenForSubmission:!1,hash:"b65658f81d14e9e57e49377869d3a575",slug:"mining-techniques-past-present-and-future",bookSignature:"Abhay Soni",coverURL:"https://cdn.intechopen.com/books/images_new/8620.jpg",editors:[{id:"271093",title:"Dr.",name:"Abhay",middleName:null,surname:"Soni",slug:"abhay-soni",fullName:"Abhay Soni"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9660",title:"Inland Waters",subtitle:"Dynamics and Ecology",isOpenForSubmission:!1,hash:"975c26819ceb11a926793bc2adc62bd6",slug:"inland-waters-dynamics-and-ecology",bookSignature:"Adam Devlin, Jiayi Pan and Mohammad Manjur Shah",coverURL:"https://cdn.intechopen.com/books/images_new/9660.jpg",editors:[{id:"280757",title:"Dr.",name:"Adam",middleName:"Thomas",surname:"Devlin",slug:"adam-devlin",fullName:"Adam Devlin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}},{type:"book",id:"9122",title:"Cosmetic Surgery",subtitle:null,isOpenForSubmission:!1,hash:"207026ca4a4125e17038e770d00ee152",slug:"cosmetic-surgery",bookSignature:"Yueh-Bih Tang",coverURL:"https://cdn.intechopen.com/books/images_new/9122.jpg",editors:[{id:"202122",title:"Prof.",name:"Yueh-Bih",middleName:null,surname:"Tang",slug:"yueh-bih-tang",fullName:"Yueh-Bih Tang"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],latestBooks:[{type:"book",id:"9550",title:"Entrepreneurship",subtitle:"Contemporary Issues",isOpenForSubmission:!1,hash:"9b4ac1ee5b743abf6f88495452b1e5e7",slug:"entrepreneurship-contemporary-issues",bookSignature:"Mladen Turuk",coverURL:"https://cdn.intechopen.com/books/images_new/9550.jpg",editedByType:"Edited by",editors:[{id:"319755",title:"Prof.",name:"Mladen",middleName:null,surname:"Turuk",slug:"mladen-turuk",fullName:"Mladen Turuk"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10065",title:"Wavelet Theory",subtitle:null,isOpenForSubmission:!1,hash:"d8868e332169597ba2182d9b004d60de",slug:"wavelet-theory",bookSignature:"Somayeh Mohammady",coverURL:"https://cdn.intechopen.com/books/images_new/10065.jpg",editedByType:"Edited by",editors:[{id:"109280",title:"Dr.",name:"Somayeh",middleName:null,surname:"Mohammady",slug:"somayeh-mohammady",fullName:"Somayeh Mohammady"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9313",title:"Clay Science and Technology",subtitle:null,isOpenForSubmission:!1,hash:"6fa7e70396ff10620e032bb6cfa6fb72",slug:"clay-science-and-technology",bookSignature:"Gustavo Morari Do Nascimento",coverURL:"https://cdn.intechopen.com/books/images_new/9313.jpg",editedByType:"Edited by",editors:[{id:"7153",title:"Prof.",name:"Gustavo",middleName:null,surname:"Morari Do Nascimento",slug:"gustavo-morari-do-nascimento",fullName:"Gustavo Morari Do Nascimento"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9888",title:"Nuclear Power Plants",subtitle:"The Processes from the Cradle to the Grave",isOpenForSubmission:!1,hash:"c2c8773e586f62155ab8221ebb72a849",slug:"nuclear-power-plants-the-processes-from-the-cradle-to-the-grave",bookSignature:"Nasser Awwad",coverURL:"https://cdn.intechopen.com/books/images_new/9888.jpg",editedByType:"Edited by",editors:[{id:"145209",title:"Prof.",name:"Nasser",middleName:"S",surname:"Awwad",slug:"nasser-awwad",fullName:"Nasser Awwad"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8098",title:"Resources of Water",subtitle:null,isOpenForSubmission:!1,hash:"d251652996624d932ef7b8ed62cf7cfc",slug:"resources-of-water",bookSignature:"Prathna Thanjavur Chandrasekaran, Muhammad Salik Javaid, Aftab Sadiq",coverURL:"https://cdn.intechopen.com/books/images_new/8098.jpg",editedByType:"Edited by",editors:[{id:"167917",title:"Dr.",name:"Prathna",middleName:null,surname:"Thanjavur Chandrasekaran",slug:"prathna-thanjavur-chandrasekaran",fullName:"Prathna Thanjavur Chandrasekaran"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9644",title:"Glaciers and the Polar Environment",subtitle:null,isOpenForSubmission:!1,hash:"e8cfdc161794e3753ced54e6ff30873b",slug:"glaciers-and-the-polar-environment",bookSignature:"Masaki Kanao, Danilo Godone and Niccolò Dematteis",coverURL:"https://cdn.intechopen.com/books/images_new/9644.jpg",editedByType:"Edited by",editors:[{id:"51959",title:"Dr.",name:"Masaki",middleName:null,surname:"Kanao",slug:"masaki-kanao",fullName:"Masaki Kanao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"10432",title:"Casting Processes and Modelling of Metallic Materials",subtitle:null,isOpenForSubmission:!1,hash:"2c5c9df938666bf5d1797727db203a6d",slug:"casting-processes-and-modelling-of-metallic-materials",bookSignature:"Zakaria Abdallah and Nada Aldoumani",coverURL:"https://cdn.intechopen.com/books/images_new/10432.jpg",editedByType:"Edited by",editors:[{id:"201670",title:"Dr.",name:"Zak",middleName:null,surname:"Abdallah",slug:"zak-abdallah",fullName:"Zak Abdallah"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9671",title:"Macrophages",subtitle:null,isOpenForSubmission:!1,hash:"03b00fdc5f24b71d1ecdfd75076bfde6",slug:"macrophages",bookSignature:"Hridayesh Prakash",coverURL:"https://cdn.intechopen.com/books/images_new/9671.jpg",editedByType:"Edited by",editors:[{id:"287184",title:"Dr.",name:"Hridayesh",middleName:null,surname:"Prakash",slug:"hridayesh-prakash",fullName:"Hridayesh Prakash"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8415",title:"Extremophilic Microbes and Metabolites",subtitle:"Diversity, Bioprospecting and Biotechnological Applications",isOpenForSubmission:!1,hash:"93e0321bc93b89ff73730157738f8f97",slug:"extremophilic-microbes-and-metabolites-diversity-bioprospecting-and-biotechnological-applications",bookSignature:"Afef Najjari, Ameur Cherif, Haïtham Sghaier and Hadda Imene Ouzari",coverURL:"https://cdn.intechopen.com/books/images_new/8415.jpg",editedByType:"Edited by",editors:[{id:"196823",title:"Dr.",name:"Afef",middleName:null,surname:"Najjari",slug:"afef-najjari",fullName:"Afef Najjari"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"9731",title:"Oxidoreductase",subtitle:null,isOpenForSubmission:!1,hash:"852e6f862c85fc3adecdbaf822e64e6e",slug:"oxidoreductase",bookSignature:"Mahmoud Ahmed Mansour",coverURL:"https://cdn.intechopen.com/books/images_new/9731.jpg",editedByType:"Edited by",editors:[{id:"224662",title:"Prof.",name:"Mahmoud Ahmed",middleName:null,surname:"Mansour",slug:"mahmoud-ahmed-mansour",fullName:"Mahmoud Ahmed Mansour"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},subject:{topic:{id:"318",title:"Pestology",slug:"animal-biology-pestology",parent:{title:"Animal Biology",slug:"animal-biology"},numberOfBooks:4,numberOfAuthorsAndEditors:183,numberOfWosCitations:405,numberOfCrossrefCitations:216,numberOfDimensionsCitations:658,videoUrl:null,fallbackUrl:null,description:null},booksByTopicFilter:{topicSlug:"animal-biology-pestology",sort:"-publishedDate",limit:12,offset:0},booksByTopicCollection:[{type:"book",id:"5252",title:"Integrated Pest Management (IPM)",subtitle:"Environmentally Sound Pest Management",isOpenForSubmission:!1,hash:"8f2c00d77debd573ce98ad0af592512a",slug:"integrated-pest-management-ipm-environmentally-sound-pest-management",bookSignature:"Harsimran Kaur Gill and Gaurav Goyal",coverURL:"https://cdn.intechopen.com/books/images_new/5252.jpg",editedByType:"Edited by",editors:[{id:"169846",title:"Dr.",name:"Harsimran",middleName:null,surname:"Gill",slug:"harsimran-gill",fullName:"Harsimran Gill"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"5067",title:"Insecticides Resistance",subtitle:null,isOpenForSubmission:!1,hash:"e0c89a15887b47c513a572364c7d9336",slug:"insecticides-resistance",bookSignature:"Stanislav Trdan",coverURL:"https://cdn.intechopen.com/books/images_new/5067.jpg",editedByType:"Edited by",editors:[{id:"78285",title:"Prof.",name:"Stanislav",middleName:null,surname:"Trdan",slug:"stanislav-trdan",fullName:"Stanislav Trdan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3055",title:"Insecticides",subtitle:"Development of Safer and More Effective Technologies",isOpenForSubmission:!1,hash:"adb06e05715aa4d3ec42f707d1626158",slug:"insecticides-development-of-safer-and-more-effective-technologies",bookSignature:"Stanislav Trdan",coverURL:"https://cdn.intechopen.com/books/images_new/3055.jpg",editedByType:"Edited by",editors:[{id:"78285",title:"Prof.",name:"Stanislav",middleName:null,surname:"Trdan",slug:"stanislav-trdan",fullName:"Stanislav Trdan"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2036",title:"Insecticides",subtitle:"Advances in Integrated Pest Management",isOpenForSubmission:!1,hash:"42dc69ce20386f76845e38275b0e54e8",slug:"insecticides-advances-in-integrated-pest-management",bookSignature:"Farzana Perveen",coverURL:"https://cdn.intechopen.com/books/images_new/2036.jpg",editedByType:"Edited by",editors:[{id:"75563",title:"Dr.",name:"Farzana Khan",middleName:null,surname:"Perveen",slug:"farzana-khan-perveen",fullName:"Farzana Khan Perveen"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],booksByTopicTotal:4,mostCitedChapters:[{id:"25677",doi:"10.5772/29495",title:"Pyrethroid Insecticides: Use, Environmental Fate, and Ecotoxicology",slug:"pyrethroid-insecticides-use-environmental-fate-and-ecotoxicology",totalDownloads:7607,totalCrossrefCites:38,totalDimensionsCites:86,book:{slug:"insecticides-advances-in-integrated-pest-management",title:"Insecticides",fullTitle:"Insecticides - Advances in Integrated Pest Management"},signatures:"Katherine Palmquist, Johanna Salatas and Anne Fairbrother",authors:[{id:"78143",title:"Dr.",name:"Katherine",middleName:null,surname:"Palmquist",slug:"katherine-palmquist",fullName:"Katherine Palmquist"},{id:"83492",title:"MSc",name:"Johanna",middleName:null,surname:"Salatas",slug:"johanna-salatas",fullName:"Johanna Salatas"},{id:"83493",title:"Dr.",name:"Anne",middleName:null,surname:"Fairbrother",slug:"anne-fairbrother",fullName:"Anne Fairbrother"}]},{id:"42208",doi:"10.5772/53355",title:"Polymeric Nanoparticle-Based Insecticides: A Controlled Release Purpose for Agrochemicals",slug:"polymeric-nanoparticle-based-insecticides-a-controlled-release-purpose-for-agrochemicals",totalDownloads:6247,totalCrossrefCites:18,totalDimensionsCites:70,book:{slug:"insecticides-development-of-safer-and-more-effective-technologies",title:"Insecticides",fullTitle:"Insecticides - Development of Safer and More Effective Technologies"},signatures:"Bruno Perlatti, Patrícia Luísa de Souza Bergo, Maria Fátima das Graças Fernandes da Silva, João Batista Fernandes and Moacir Rossi Forim",authors:[{id:"72202",title:"Dr.",name:"Moacir",middleName:"Rossi",surname:"Forim",slug:"moacir-forim",fullName:"Moacir Forim"},{id:"82255",title:"Prof.",name:"Maria Fátima",middleName:null,surname:"Da Silva",slug:"maria-fatima-da-silva",fullName:"Maria Fátima Da Silva"},{id:"83702",title:"Prof.",name:"João",middleName:null,surname:"Fernandes",slug:"joao-fernandes",fullName:"João Fernandes"},{id:"166176",title:"MSc.",name:"Bruno",middleName:null,surname:"Perlatti",slug:"bruno-perlatti",fullName:"Bruno Perlatti"},{id:"166177",title:"MSc.",name:"Patrícia Luísa",middleName:null,surname:"Bergo",slug:"patricia-luisa-bergo",fullName:"Patrícia Luísa Bergo"}]},{id:"25668",doi:"10.5772/27852",title:"Ecosmart Biorational Insecticides: Alternative Insect Control Strategies",slug:"ecosmart-biorational-insecticides-alternative-insect-control-strategies",totalDownloads:6136,totalCrossrefCites:5,totalDimensionsCites:38,book:{slug:"insecticides-advances-in-integrated-pest-management",title:"Insecticides",fullTitle:"Insecticides - Advances in Integrated Pest Management"},signatures:"Hanem Fathy Khater",authors:[{id:"71812",title:"Prof.",name:"Hanem Fathy",middleName:"Fathy",surname:"Khater",slug:"hanem-fathy-khater",fullName:"Hanem Fathy Khater"}]}],mostDownloadedChaptersLast30Days:[{id:"25682",title:"Secondary Metabolism as a Measurement of Efficacy of Botanical Extracts: The Use of Azadirachta indica (Neem) as a Model",slug:"secondary-metabolism-as-a-measurement-of-efficacy-of-botanical-extracts-the-use-of-azadirachta-indic",totalDownloads:7575,totalCrossrefCites:3,totalDimensionsCites:13,book:{slug:"insecticides-advances-in-integrated-pest-management",title:"Insecticides",fullTitle:"Insecticides - Advances in Integrated Pest Management"},signatures:"Moacir Rossi Forim, Maria Fátima das Graças Fernandes da Silva and João Batista Fernandes",authors:[{id:"72202",title:"Dr.",name:"Moacir",middleName:"Rossi",surname:"Forim",slug:"moacir-forim",fullName:"Moacir Forim"},{id:"82255",title:"Prof.",name:"Maria Fátima",middleName:null,surname:"Da Silva",slug:"maria-fatima-da-silva",fullName:"Maria Fátima Da Silva"},{id:"83702",title:"Prof.",name:"João",middleName:null,surname:"Fernandes",slug:"joao-fernandes",fullName:"João Fernandes"}]},{id:"42208",title:"Polymeric Nanoparticle-Based Insecticides: A Controlled Release Purpose for Agrochemicals",slug:"polymeric-nanoparticle-based-insecticides-a-controlled-release-purpose-for-agrochemicals",totalDownloads:6248,totalCrossrefCites:18,totalDimensionsCites:70,book:{slug:"insecticides-development-of-safer-and-more-effective-technologies",title:"Insecticides",fullTitle:"Insecticides - Development of Safer and More Effective Technologies"},signatures:"Bruno Perlatti, Patrícia Luísa de Souza Bergo, Maria Fátima das Graças Fernandes da Silva, João Batista Fernandes and Moacir Rossi Forim",authors:[{id:"72202",title:"Dr.",name:"Moacir",middleName:"Rossi",surname:"Forim",slug:"moacir-forim",fullName:"Moacir Forim"},{id:"82255",title:"Prof.",name:"Maria Fátima",middleName:null,surname:"Da Silva",slug:"maria-fatima-da-silva",fullName:"Maria Fátima Da Silva"},{id:"83702",title:"Prof.",name:"João",middleName:null,surname:"Fernandes",slug:"joao-fernandes",fullName:"João Fernandes"},{id:"166176",title:"MSc.",name:"Bruno",middleName:null,surname:"Perlatti",slug:"bruno-perlatti",fullName:"Bruno Perlatti"},{id:"166177",title:"MSc.",name:"Patrícia Luísa",middleName:null,surname:"Bergo",slug:"patricia-luisa-bergo",fullName:"Patrícia Luísa Bergo"}]},{id:"42191",title:"Side Effects of Insecticides on Natural Enemies and Possibility of Their Integration in Plant Protection Strategies",slug:"side-effects-of-insecticides-on-natural-enemies-and-possibility-of-their-integration-in-plant-protec",totalDownloads:4993,totalCrossrefCites:16,totalDimensionsCites:32,book:{slug:"insecticides-development-of-safer-and-more-effective-technologies",title:"Insecticides",fullTitle:"Insecticides - Development of Safer and More Effective Technologies"},signatures:"Nabil El-Wakeil, Nawal Gaafar, Ahmed Sallam and Christa Volkmar",authors:[{id:"80199",title:"Prof.",name:"Christa",middleName:null,surname:"Volkmar",slug:"christa-volkmar",fullName:"Christa Volkmar"},{id:"82718",title:"Dr.",name:"Nabil",middleName:null,surname:"El-Wakeil",slug:"nabil-el-wakeil",fullName:"Nabil El-Wakeil"},{id:"83353",title:"Dr.",name:"Ahmed",middleName:"Ahmed",surname:"Sallam",slug:"ahmed-sallam",fullName:"Ahmed Sallam"},{id:"83363",title:"Dr.",name:"Nawal",middleName:null,surname:"Gaafar",slug:"nawal-gaafar",fullName:"Nawal Gaafar"}]},{id:"49257",title:"Mosquito-Borne Diseases, Pesticides Used for Mosquito Control, and Development of Resistance to Insecticides",slug:"mosquito-borne-diseases-pesticides-used-for-mosquito-control-and-development-of-resistance-to-insect",totalDownloads:2494,totalCrossrefCites:1,totalDimensionsCites:5,book:{slug:"insecticides-resistance",title:"Insecticides Resistance",fullTitle:"Insecticides Resistance"},signatures:"Jaime A. Cuervo-Parra, Teresa Romero Cortés and Mario Ramirez-\nLepe",authors:[{id:"76645",title:"Dr.",name:"Mario",middleName:null,surname:"Ramirez-Lepe",slug:"mario-ramirez-lepe",fullName:"Mario Ramirez-Lepe"},{id:"177394",title:"Dr.",name:"Jaime Alioscha",middleName:null,surname:"Cuervo-Parra",slug:"jaime-alioscha-cuervo-parra",fullName:"Jaime Alioscha Cuervo-Parra"},{id:"177395",title:"Dr.",name:"Teresa",middleName:null,surname:"Romero-Cortes",slug:"teresa-romero-cortes",fullName:"Teresa Romero-Cortes"}]},{id:"40497",title:"Impact of Systemic Insecticides on Organisms and Ecosystems",slug:"impact-of-systemic-insecticides-on-organisms-and-ecosystems",totalDownloads:3199,totalCrossrefCites:9,totalDimensionsCites:31,book:{slug:"insecticides-development-of-safer-and-more-effective-technologies",title:"Insecticides",fullTitle:"Insecticides - Development of Safer and More Effective Technologies"},signatures:"Francisco Sánchez-Bayo, Henk A. Tennekes and Koichi Goka",authors:[{id:"74970",title:"Dr.",name:"Francisco",middleName:null,surname:"Sánchez-Bayo",slug:"francisco-sanchez-bayo",fullName:"Francisco Sánchez-Bayo"}]},{id:"42222",title:"Use of Botanicals and Safer Insecticides Designed in Controlling Insects: The African Case",slug:"use-of-botanicals-and-safer-insecticides-designed-in-controlling-insects-the-african-case",totalDownloads:3810,totalCrossrefCites:3,totalDimensionsCites:17,book:{slug:"insecticides-development-of-safer-and-more-effective-technologies",title:"Insecticides",fullTitle:"Insecticides - Development of Safer and More Effective Technologies"},signatures:"Patrick Kareru, Zachaeus Kipkorir Rotich and Esther Wamaitha Maina",authors:[{id:"75493",title:"Dr.",name:"Patrick",middleName:null,surname:"Kareru",slug:"patrick-kareru",fullName:"Patrick Kareru"},{id:"166178",title:"Mr.",name:"Zachaeus",middleName:null,surname:"Kipkorir Rotich",slug:"zachaeus-kipkorir-rotich",fullName:"Zachaeus Kipkorir Rotich"},{id:"166179",title:"Ms.",name:"Esther",middleName:null,surname:"Wamaitha Maina",slug:"esther-wamaitha-maina",fullName:"Esther Wamaitha Maina"}]},{id:"42342",title:"The Use of Behavioral Manipulation Techniques On Synthetic Insecticides Optimization",slug:"the-use-of-behavioral-manipulation-techniques-on-synthetic-insecticides-optimization",totalDownloads:2093,totalCrossrefCites:0,totalDimensionsCites:0,book:{slug:"insecticides-development-of-safer-and-more-effective-technologies",title:"Insecticides",fullTitle:"Insecticides - Development of Safer and More Effective Technologies"},signatures:"Solange Maria de França, Mariana Oliveira Breda, Cesar A. Badji and José Vargas de Oliveira",authors:[{id:"72398",title:"MSc",name:"Solange",middleName:"Maria",surname:"De França",slug:"solange-de-franca",fullName:"Solange De França"},{id:"161232",title:"MSc.",name:"Mariana",middleName:null,surname:"Breda",slug:"mariana-breda",fullName:"Mariana Breda"},{id:"161233",title:"Prof.",name:"César",middleName:null,surname:"Badji",slug:"cesar-badji",fullName:"César Badji"},{id:"166063",title:"Prof.",name:"José Vargas",middleName:null,surname:"Oliveira",slug:"jose-vargas-oliveira",fullName:"José Vargas Oliveira"}]},{id:"42343",title:"The Performance of Insecticides – A Critical Review",slug:"the-performance-of-insecticides-a-critical-review",totalDownloads:1879,totalCrossrefCites:6,totalDimensionsCites:8,book:{slug:"insecticides-development-of-safer-and-more-effective-technologies",title:"Insecticides",fullTitle:"Insecticides - Development of Safer and More Effective Technologies"},signatures:"Christian Nansen and James Thomas Ridsdill-Smith",authors:[{id:"161196",title:"Associate Prof.",name:"Christian",middleName:null,surname:"Nansen",slug:"christian-nansen",fullName:"Christian Nansen"}]},{id:"51810",title:"Using Semiochemicals for Coleopterean Pests in Sustainable Plant Protection",slug:"using-semiochemicals-for-coleopterean-pests-in-sustainable-plant-protection",totalDownloads:1293,totalCrossrefCites:1,totalDimensionsCites:1,book:{slug:"integrated-pest-management-ipm-environmentally-sound-pest-management",title:"Integrated Pest Management (IPM)",fullTitle:"Integrated Pest Management (IPM): Environmentally Sound Pest Management"},signatures:"Maria Pojar-Fenesan and Ana Balea",authors:[{id:"179873",title:"Dr.",name:"Maria",middleName:null,surname:"Pojar-Fenesan",slug:"maria-pojar-fenesan",fullName:"Maria Pojar-Fenesan"},{id:"181696",title:"Dr.",name:"Ana",middleName:null,surname:"Balea",slug:"ana-balea",fullName:"Ana Balea"}]},{id:"25668",title:"Ecosmart Biorational Insecticides: Alternative Insect Control Strategies",slug:"ecosmart-biorational-insecticides-alternative-insect-control-strategies",totalDownloads:6136,totalCrossrefCites:5,totalDimensionsCites:38,book:{slug:"insecticides-advances-in-integrated-pest-management",title:"Insecticides",fullTitle:"Insecticides - Advances in Integrated Pest Management"},signatures:"Hanem Fathy Khater",authors:[{id:"71812",title:"Prof.",name:"Hanem Fathy",middleName:"Fathy",surname:"Khater",slug:"hanem-fathy-khater",fullName:"Hanem Fathy Khater"}]}],onlineFirstChaptersFilter:{topicSlug:"animal-biology-pestology",limit:3,offset:0},onlineFirstChaptersCollection:[],onlineFirstChaptersTotal:0},preDownload:{success:null,errors:{}},aboutIntechopen:{},privacyPolicy:{},peerReviewing:{},howOpenAccessPublishingWithIntechopenWorks:{},sponsorshipBooks:{sponsorshipBooks:[{type:"book",id:"10176",title:"Microgrids and Local Energy Systems",subtitle:null,isOpenForSubmission:!0,hash:"c32b4a5351a88f263074b0d0ca813a9c",slug:null,bookSignature:"Prof. Nick Jenkins",coverURL:"https://cdn.intechopen.com/books/images_new/10176.jpg",editedByType:null,editors:[{id:"55219",title:"Prof.",name:"Nick",middleName:null,surname:"Jenkins",slug:"nick-jenkins",fullName:"Nick Jenkins"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter"}}],offset:8,limit:8,total:1},route:{name:"chapter.detail",path:"/books/oxidative-stress-molecular-mechanisms-and-biological-effects/complex-regulatory-interplay-between-multidrug-resistance-and-oxidative-stress-response-in-yeast-th",hash:"",query:{},params:{book:"oxidative-stress-molecular-mechanisms-and-biological-effects",chapter:"complex-regulatory-interplay-between-multidrug-resistance-and-oxidative-stress-response-in-yeast-th"},fullPath:"/books/oxidative-stress-molecular-mechanisms-and-biological-effects/complex-regulatory-interplay-between-multidrug-resistance-and-oxidative-stress-response-in-yeast-th",meta:{},from:{name:null,path:"/",hash:"",query:{},params:{},fullPath:"/",meta:{}}}},function(){var e;(e=document.currentScript||document.scripts[document.scripts.length-1]).parentNode.removeChild(e)}()